1 | C-028380 | - | - | - | - | 1件: 106 106 💬
|
2 | C-1-esterase | - | - | - | - | 1件: 65 65 💬
|
3 | C-11 ER176 | - | - | - | - | 3件: 6 6, 17, 127 💬
|
4 | C-11 ER176 radiotracer | - | - | - | - | 1件: 13 13 💬
|
5 | C-11 PIB | 1件: Pittsburgh Compound B Pittsburgh Compound B | - | - | - | 3件: 6 6, 17, 127 💬
|
6 | C-KIT+ cells | - | - | - | - | 1件: 211 211 💬
|
7 | C-type natriuretic peptide conjugated TO A multi-ARM polyethylene glycol carrier molecule through A cleavable linker | - | - | - | - | 1件: 276 276 💬
|
8 | C-type natriuretic peptide conjugated TO multi-ARM polyethylene glycol carrier through A cleavable linker | - | - | - | - | 1件: 276 276 💬
|
9 | C. albicans | - | - | - | - | 1件: 46 46 💬
|
10 | C01ca04 - dopamina | - | - | - | - | 1件: 299 299 💬
|
11 | C01eb19 | - | - | - | - | 1件: 65 65 💬
|
12 | C03xa01 | - | - | - | - | 2件: 67 67, 72 💬
|
13 | C07ab07 | - | - | - | - | 1件: 86 86 💬
|
14 | C09 | - | - | - | - | 1件: 66 66 💬
|
15 | C1 esterase inhibitor | - | - | - | - | 1件: 65 65 💬
|
16 | C1 esterase inhibitor [human] liquid | - | - | - | - | 1件: 65 65 💬
|
17 | C1 esterase inhibitor concentrate | - | - | - | - | 1件: 65 65 💬
|
18 | C1 esterase inhibitor concentrate, human, pasteurized | - | - | - | - | 1件: 65 65 💬
|
19 | C1 esterase inhibitor human | - | - | - | - | 1件: 65 65 💬
|
20 | C1 esterase inhibitor liquid FOR injection | - | - | - | - | 1件: 65 65 💬
|
21 | C1 inhibitor | 1件: Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | 1件: 65 65 💬
|
22 | C1 inhibitor concentrate | 1件: Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | 1件: 65 65 💬
|
23 | C1-esterase inhibitor | - | - | - | - | 1件: 65 65 💬
|
24 | C1-esterase inhibitor - single intravenous dose | - | - | - | - | 1件: 65 65 💬
|
25 | C1-esterase inhibitor - subcutaneous high dose | - | - | - | - | 1件: 65 65 💬
|
26 | C1-esterase inhibitor - subcutaneous LOW dose | - | - | - | - | 1件: 65 65 💬
|
27 | C1-esterase inhibitor - subcutaneous medium dose | - | - | - | - | 1件: 65 65 💬
|
28 | C1-esterase-inhibitor | - | - | - | - | 1件: 65 65 💬
|
29 | C1-INH | 1件: Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | 1件: 65 65 💬
|
30 | C105 | - | - | - | - | 1件: 13 13 💬
|
31 | C106 solution | - | - | - | - | 1件: 85 85 💬
|
32 | C10aa05 | - | - | - | - | 1件: 46 46 💬
|
33 | C10ab02 | - | - | - | - | 1件: 94 94 💬
|
34 | C11 pittsburgh compound B | - | - | - | - | 1件: 13 13 💬
|
35 | C11-methionine | - | - | - | - | 1件: 84 84 💬
|
36 | C11-SY08 | - | - | - | - | 2件: 6 6, 17 💬
|
37 | C21 | - | - | - | - | 2件: 51 51, 85 💬
|
38 | C225 | - | - | - | - | 2件: 51 51, 86 💬
|
39 | C2L-OCT-01 PR | - | - | - | - | 1件: 77 77 💬
|
40 | C2L-OCT-01 PR , 10MG | - | - | - | - | 1件: 77 77 💬
|
41 | C2L-OCT-01 PR , 20MG | - | - | - | - | 1件: 77 77 💬
|
42 | C2L-OCT-01 PR , 30MG | - | - | - | - | 1件: 77 77 💬
|
43 | C2L-OCT-01 PR 30 MG | - | - | - | - | 1件: 77 77 💬
|
44 | C2L-OCT-01 PR, 10 or 20 MG | - | - | - | - | 1件: 77 77 💬
|
45 | C2L-OCT-01 PR, 20 MG | - | - | - | - | 1件: 77 77 💬
|
46 | C2L-OCT-01 PR, 30 MG | - | - | - | - | 1件: 77 77 💬
|
47 | C326, IL-6 inhibitory avimer protein | 1件: C326 C326 | - | - | - | 1件: 96 96 💬
|
48 | C5 INH MAB, SKY59, RO/CH7092230 | - | - | - | - | 2件: 62 62, 109 💬
|
49 | C5 inhibitor | - | - | - | - | 1件: 62 62 💬
|
50 | CA2 | - | - | - | - | 1件: 271 271 💬
|
51 | CABA-201 | - | - | - | - | 3件: 11 11, 49, 51 💬
|
52 | CABA-201 following preconditioning with fludarabine and cyclophosphamide | - | - | - | - | 1件: 50 50 💬
|
53 | Cabaletta | 1件: Trehalose Trehalose | - | - | - | 1件: 113 113 💬
|
54 | Cabaletta FOR IV infusion once weekly during 24 weeks | 1件: Trehalose Trehalose | - | - | - | 1件: 18 18 💬
|
55 | Cabaser | - | - | - | - | 2件: 6 6, 77 💬
|
56 | Cabaseril | - | - | - | - | 1件: 6 6 💬
|
57 | Cabaseril, 1,0 MG tablette | - | - | - | - | 1件: 6 6 💬
|
58 | Cabaseril, 2,0 MG tablette | - | - | - | - | 1件: 6 6 💬
|
59 | Cabergolin | - | - | - | - | 1件: 77 77 💬
|
60 | Cabergolina | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 75 💬
|
61 | Cabergoline | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 4件: 6 6, 74, 75, 77 💬
|
62 | Cabergoline teva | 1件: Cabergoline Cabergoline | 1件: Cabergoline
Cabergoline
💬
| 2件: DRD2 DRD2, PRL 💬
| 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
63 | Cablivi | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
💬
| 1件: VWF VWF 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|
64 | Cablivi® | - | - | - | - | 1件: 64 64 💬
|
65 | Cabozantinib | 1件: Cabozantinib Cabozantinib | 2件: Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| 3件: AXL AXL, KDR, MET 💬
| 25件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 💬
|
66 | Cabozantinib oral tablet | 1件: Cabozantinib Cabozantinib | 2件: Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| 3件: AXL AXL, KDR, MET 💬
| 25件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 💬
|
67 | Cacipliq20 | - | - | - | - | 1件: 36 36 💬
|
68 | Cacit D3 effervescent granules, 500 MG/440 IU | - | - | - | - | 1件: 97 97 💬
|
69 | CADD-legacy ambulatory infusion pump | - | - | - | - | 1件: 6 6 💬
|
70 | CADD-legacy® 1400 ambulatory infusion pump | - | - | - | - | 1件: 6 6 💬
|
71 | CAEL-101 | - | - | - | - | 1件: 28 28 💬
|
72 | Caffeic acid tablets | - | - | - | - | 1件: 63 63 💬
|
73 | Caffeine | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
74 | Caffeine 100 MG | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 96 96, 97 💬
|
75 | Caffeine 100-200 MG BID | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
76 | Caffeine alkaloid | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
77 | CAL101 | - | - | - | - | 1件: 85 85 💬
|
78 | Calcichew D3 | - | - | - | - | 1件: 274 274 💬
|
79 | Calcichew D3 forte | - | - | - | - | 1件: 113 113 💬
|
80 | Calcichew tablets | - | - | - | - | 1件: 274 274 💬
|
81 | Calcifediol | 1件: Calcifediol Calcifediol | 1件: Calcifediol
Calcifediol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 113 113 💬
|
82 | Calcifediol oral capsule | 1件: Calcifediol Calcifediol | 1件: Calcifediol
Calcifediol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 86 86 💬
|
83 | Calciferol | 1件: Vitamin D Vitamin D | - | - | - | 1件: 49 49 💬
|
84 | Calcineurin inhibitors | - | - | - | - | 1件: 50 50 💬
|
85 | Calcineurin inhibitors maintenance | - | - | - | - | 1件: 67 67 💬
|
86 | Calcio | 1件: Calcium Calcium | - | - | - | 3件: 13 13, 96, 97 💬
|
87 | Calcio carbonato/colecalciferolo | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 274 274 💬
|
88 | Calcipotriene | 1件: Calcipotriol Calcipotriol | 2件: Calcipotriene
Calcipotriene
,
Calcipotriol hydrate
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 51 51 💬
|
89 | Calcipotriol | 1件: Calcipotriol Calcipotriol | 2件: Calcipotriene
Calcipotriene
,
Calcipotriol hydrate
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 36 36 💬
|
90 | Calcitonin | - | - | - | - | 1件: 225 225 💬
|
91 | Calcitriol | 1件: Calcitriol Calcitriol | 1件: Calcitriol
Calcitriol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 8件: 18 18, 37, 46, 49, 66, 96, 235, 326 💬
|
92 | Calcitriol & calcium | 1件: Calcitriol Calcitriol | 1件: Calcitriol
Calcitriol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 235 235 💬
|
93 | Calcium | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 12件: 6 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
|
94 | Calcium and cholecalciferol | 2件: Calcium Calcium, Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 46 46 💬
|
95 | Calcium and VIT D | 1件: Calcium Calcium | - | - | - | 1件: 49 49 💬
|
96 | Calcium and vitamin D combination | 1件: Calcium Calcium | - | - | - | 1件: 13 13 💬
|
97 | Calcium carbonate | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 7件: 13 13, 19, 46, 75, 96, 235, 299 💬
|
98 | Calcium carbonate 600 MG once daily | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 97 97 💬
|
99 | Calcium carbonate and alphacalcidol | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 235 235 💬
|
100 | Calcium carbonate D | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 53 53 💬
|
101 | Calcium carbonate tablets | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 46 46 💬
|
102 | Calcium channel blockers | 1件: Calcium Calcium | - | - | - | 1件: 51 51 💬
|
103 | Calcium citrate | 3件: Calcium Calcium, Calcium carbonate, Calcium citrate | 3件: Calcium carbonate
Calcium carbonate
,
Calcium citrate
,
Calcium carbonate
💬
| - | - | 2件: 46 46, 235 💬
|
104 | Calcium citrate with vitamin D2 | 3件: Calcium Calcium, Calcium citrate, Ergocalciferol | 2件: Ergocalciferol
Ergocalciferol
,
Calcium citrate
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 84 84 💬
|
105 | Calcium D3 sandoz - 1000 MG + 880 U.I. compresse effervescenti 30 compresse divisibili | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 1件: 274 274 💬
|
106 | Calcium gluconate | 2件: Calcium Calcium, Calcium gluconate | 1件: Calcium gluconate
Calcium gluconate
💬
| - | - | 3件: 214 214, 215, 235 💬
|
107 | Calcium lactate | 2件: Calcium Calcium, Calcium lactate | 2件: Calcium lactate
Calcium lactate
,
Calcium lactate hydrate
💬
| - | - | 1件: 235 235 💬
|
108 | Calcium levofolinate | 1件: Calcium Calcium | - | - | - | 1件: 13 13 💬
|
109 | Calcium stable isotope | 1件: Calcium Calcium | - | - | - | 1件: 186 186 💬
|
110 | Calcium, dietary | 1件: Calcium Calcium | - | - | - | 1件: 298 298 💬
|
111 | Calculus bovis | 1件: Bos taurus gallstone Bos taurus gallstone | - | - | - | 1件: 13 13 💬
|
112 | Calfactant | 1件: Calfactant Calfactant | 1件: Calfactant
Calfactant
💬
| - | - | 1件: 299 299 💬
|
113 | Calogen | - | - | - | - | 1件: 2 2 💬
|
114 | Calprotectin | - | - | - | - | 1件: 97 97 💬
|
115 | Caltrate | - | - | - | - | 1件: 97 97 💬
|
116 | Caltrate pill | - | - | - | - | 1件: 96 96 💬
|
117 | Calvan tablets 100 | - | - | - | - | 1件: 8 8 💬
|
118 | Calvan® 100 MG | - | - | - | - | 1件: 8 8 💬
|
119 | CALY-002 | 1件: CALY-002 CALY-002 | - | - | - | 1件: 98 98 💬
|
120 | CAM-3001 | 1件: Mavrilimumab Mavrilimumab | 1件: Mavrilimumab
Mavrilimumab
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 💬
|
121 | CAM2029 | - | - | - | - | 1件: 77 77 💬
|
122 | CAM2029 (octreotide subcutaneous depot) _prefilled syringe_prefilled syringe | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
123 | CAM2029 (octreotide subcutaneous depot)_ prefilled PEN | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
124 | CAM2029 (octreotide subcutaneous depot)_ prefilled syringe | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
125 | CAM2029 (octreotide subcutaneous depot)_pre-filled PEN | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
126 | CAM2029 (octreotide subcutaneous depot)_pre-filled syringe | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
127 | CAM2029 (octreotide subcutaneous depot)_prefilled PEN | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
128 | CAM2029 (octreotide subcutaneous depot)_prefilled syringe | 1件: Octreotide Octreotide | 4件: Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
💬
| 1件: SSTR2 SSTR2 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
129 | CAM2029-BR | - | - | - | - | 1件: 77 77 💬
|
130 | CAM2043 | - | - | - | - | 1件: 51 51 💬
|
131 | Camoteskimab | 1件: Camoteskimab Camoteskimab | - | - | - | 1件: 54 54 💬
|
132 | Campath | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 3件: 49 49, 51, 60 💬
|
133 | Campath -1H | - | - | - | - | 1件: 65 65 💬
|
134 | Campath 1H | - | - | - | - | 4件: 60 60, 65, 164, 285 💬
|
135 | Campath, busulfan, clofarabine | - | - | - | - | 1件: 326 326 💬
|
136 | Campath, chemo and/or TBI allo SCT | - | - | - | - | 3件: 60 60, 62, 283 💬
|
137 | Campath, fludarabine, cyclophosphamide | - | - | - | - | 2件: 65 65, 284 💬
|
138 | Campath-1H | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 6件: 19 19, 20, 60, 65, 234, 326 💬
|
139 | Canakinumab | 1件: Canakinumab Canakinumab | 1件: Canakinumab
Canakinumab
💬
| 1件: IL1B IL1B 💬
| 43件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 11件: 46 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
140 | Canakinumab - proposed | 1件: Canakinumab Canakinumab | 1件: Canakinumab
Canakinumab
💬
| 1件: IL1B IL1B 💬
| 43件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 1件: 106 106 💬
|
141 | Canakinumab injection | 1件: Canakinumab Canakinumab | 1件: Canakinumab
Canakinumab
💬
| 1件: IL1B IL1B 💬
| 43件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 1件: 46 46 💬
|
142 | Candesartan | 1件: Candesartan Candesartan | 1件: Candesartan
Candesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 58 58, 67 💬
|
143 | Candesartan and cilnidipine | 1件: Candesartan Candesartan | 1件: Candesartan
Candesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 67 67 💬
|
144 | Candesartan plus NON-CCB agents | 1件: Candesartan Candesartan | 1件: Candesartan
Candesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 67 67 💬
|
145 | Candy glucose tolerance test | - | - | - | - | 1件: 299 299 💬
|
146 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
|
147 | Cannabidiol , synthetic form | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 96 96 💬
|
148 | Cannabidiol / dronabinol capsule 5 MG+2,5 MG | 2件: Cannabidiol Cannabidiol, Dronabinol | 2件: Dronabinol
Dronabinol
,
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
149 | Cannabidiol 100 MG/ML | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
150 | Cannabidiol 300 MG/ML | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
151 | Cannabidiol 400 MG/ML | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 💬
|
152 | Cannabidiol capsule 5 MG | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 💬
|
153 | Cannabidiol oral solution | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 140 140, 144, 145, 193 💬
|
154 | Cannabidiol tablet 10 MG | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 46 46, 271 💬
|
155 | Cannabidiol vaginal suppository | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 226 226 💬
|
156 | Cannabidiolo | - | - | - | - | 1件: 156 156 💬
|
157 | Cannabigerol | 1件: Cannabigerol Cannabigerol | - | - | - | 1件: 46 46 💬
|
158 | Cannabinol | 1件: Cannabinol Cannabinol | - | - | - | 1件: 36 36 💬
|
159 | Cannabis | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 3件: 13 13, 46, 90 💬
|
160 | Cannabis OIL | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 1件: 6 6 💬
|
161 | Cannabis questionnaire | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 2件: 46 46, 271 💬
|
162 | Cannabis sativa extract oromucosal spray | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 1件: 2 2 💬
|
163 | Cannabis sativa L., folium CUM flore | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 1件: 19 19 💬
|
164 | Cannabis, medical | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
165 | Cannador | - | - | - | - | 1件: 13 13 💬
|
166 | CAP-1002 | - | - | - | - | 1件: 113 113 💬
|
167 | Capacity OF muscular oxygen extraction | - | - | - | - | 1件: 13 13 💬
|
168 | Capecitabine | 1件: Capecitabine Capecitabine | 1件: Capecitabine
Capecitabine
💬
| 1件: thyA thyA 💬
| 3件: Folate transport and metabolism Folate transport and metabolism, One carbon pool by folate, Pyrimidine metabolism 💬 | 1件: 94 94 💬
|
169 | Capillarema | - | - | - | - | 1件: 51 51 💬
|
170 | Caplacizumab | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
💬
| 1件: VWF VWF 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 2件: 63 63, 64 💬
|
171 | Caprylic triglyceride | 1件: Tricaprylin Tricaprylin | 1件: Tricaprilin
Tricaprilin
💬
| - | - | 1件: 13 13 💬
|
172 | Capsaicin | 1件: Capsaicin Capsaicin | 1件: Capsaicin
Capsaicin
💬
| 1件: TRPV1 TRPV1 💬
| 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 4件: 2 2, 6, 86, 226 💬
|
173 | Capsaicin challenge | 1件: Capsaicin Capsaicin | 1件: Capsaicin
Capsaicin
💬
| 1件: TRPV1 TRPV1 💬
| 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 💬
|
174 | Capsaicin vapor | 1件: Capsaicin Capsaicin | 1件: Capsaicin
Capsaicin
💬
| 1件: TRPV1 TRPV1 💬
| 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 💬
|
175 | Capsule DI prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
176 | Capsule endoscopy | - | - | - | - | 1件: 96 96 💬
|
177 | Captopril | 1件: Captopril Captopril | 1件: Captopril
Captopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 2件: 17 17, 86 💬
|
178 | Capture | 1件: Bifenthrin Bifenthrin | - | - | - | 2件: 46 46, 149 💬
|
179 | CAR T cell | - | - | - | - | 1件: 50 50 💬
|
180 | CAR-NK cell | - | - | - | - | 1件: 53 53 💬
|
181 | CAR-T cell | - | - | - | - | 1件: 49 49 💬
|
182 | CAR-T cells | - | - | - | - | 1件: 63 63 💬
|
183 | CAR-T therapy | - | - | - | - | 2件: 49 49, 51 💬
|
184 | Carbaglu | 1件: Carglumic acid Carglumic acid | 1件: Carglumic acid
Carglumic acid
💬
| 1件: CPS1 CPS1 💬
| 3件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬 | 2件: 245 245, 246 💬
|
185 | Carbamazepine | 1件: Carbamazepine Carbamazepine | 1件: Carbamazepine
Carbamazepine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 6 6, 13, 231 💬
|
186 | Carbetocin | 1件: Carbetocin Carbetocin | 1件: Carbetocin
Carbetocin
💬
| 1件: OXTR OXTR 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 193 193 💬
|
187 | Carbidopa | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 5件: 6 6, 13, 17, 140, 201 💬
|
188 | Carbidopa 20 MG | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
189 | Carbidopa 200MG oral dose | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
190 | Carbidopa 25/levodopa 100MG TAB | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
191 | Carbidopa 27.5 MG | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
192 | Carbidopa 65 MG capsule | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
193 | Carbidopa and levodopa controlled release tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
194 | Carbidopa and levodopa tablets, USP | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
195 | Carbidopa anidra | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
196 | Carbidopa INN | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
197 | Carbidopa levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
198 | Carbidopa monohydrate | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
199 | Carbidopa pill | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
200 | Carbidopa, levodopa, entacapone | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
201 | Carbidopa- levodopa | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
202 | Carbidopa-4'-monophosphate | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
203 | Carbidopa-levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
204 | Carbidopa-levodopa 25 MG-100 MG oral tablet | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
205 | Carbidopa/L-dopa/entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 18件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
206 | Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
207 | Carbidopa/levodopa, AS prescribed BY treating physician | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
208 | Carbidopa/levodopa, immediate release | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
209 | Carbidopa/levodopa/entacapone | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
210 | Carbidopamonohydraat | - | - | - | - | 1件: 6 6 💬
|
211 | Carbodopa levadopa | - | - | - | - | 1件: 6 6 💬
|
212 | Carbodopa/levadopa | - | - | - | - | 1件: 6 6 💬
|
213 | Carbohydrates intake | - | - | - | - | 1件: 257 257 💬
|
214 | Carbolithium | - | - | - | - | 1件: 2 2 💬
|
215 | Carbolithium*100CPS 150MG | - | - | - | - | 1件: 2 2 💬
|
216 | Carbomer | 1件: Carbomer Carbomer | - | - | - | 1件: 53 53 💬
|
217 | Carbomer 974P | 2件: Carbomer Carbomer, Carbopol 974P | - | - | - | 1件: 53 53 💬
|
218 | Carbomer GEL/jelly | 1件: Carbomer Carbomer | - | - | - | 1件: 53 53 💬
|
219 | Carbon | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 4件: 6 6, 97, 149, 235 💬
|
220 | Carbon dioxide | 2件: Activated charcoal Activated charcoal, Carbon dioxide | 2件: Carbon dioxide
Carbon dioxide
,
Charcoal, activated
💬
| - | - | 2件: 51 51, 158 💬
|
221 | Carbon dioxide insufflation | 2件: Activated charcoal Activated charcoal, Carbon dioxide | 2件: Carbon dioxide
Carbon dioxide
,
Charcoal, activated
💬
| - | - | 1件: 97 97 💬
|
222 | Carbon dioxide insufflation during colonoscopy | 2件: Activated charcoal Activated charcoal, Carbon dioxide | 2件: Carbon dioxide
Carbon dioxide
,
Charcoal, activated
💬
| - | - | 1件: 97 97 💬
|
223 | Carbon monoxide | 2件: Activated charcoal Activated charcoal, Carbon monoxide | 2件: Charcoal, activated
Charcoal, activated
,
Carbon monoxide
💬
| - | - | 1件: 86 86 💬
|
224 | Carbon monoxide-bubbled mediums | 2件: Activated charcoal Activated charcoal, Carbon monoxide | 2件: Charcoal, activated
Charcoal, activated
,
Carbon monoxide
💬
| - | - | 1件: 298 298 💬
|
225 | Carbon-14 BIA 28-6156 | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 1件: 6 6 💬
|
226 | Carbon-14 labeled HSK39297 | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 1件: 62 62 💬
|
227 | Carbonate DE lithium | 1件: Carbonate ion Carbonate ion | - | - | - | 1件: 2 2 💬
|
228 | Carbone vegetale polvere | - | - | - | - | 1件: 13 13 💬
|
229 | Carboplatin | 1件: Carboplatin Carboplatin | 1件: Carboplatin
Carboplatin
💬
| - | - | 4件: 28 28, 34, 60, 85 💬
|
230 | Carbossimaltosio ferrico | - | - | - | - | 1件: 97 97 💬
|
231 | Carboxy methyl cellulose | - | - | - | - | 1件: 53 53 💬
|
232 | Carboxymethylcellulose | 1件: Carboxymethylcellulose Carboxymethylcellulose | 2件: Carboxymethylcellulose sodium
Carboxymethylcellulose sodium
,
Carmellose
💬
| - | - | 2件: 35 35, 162 💬
|
233 | Cardiac evaluation | - | - | - | - | 1件: 3 3 💬
|
234 | Cardiac monitoring | - | - | - | - | 1件: 6 6 💬
|
235 | Cardiac MRI | - | - | - | - | 3件: 113 113, 215, 216 💬
|
236 | Cardiac progenitor cell infusion | - | - | - | - | 2件: 210 210, 211 💬
|
237 | Cardiomems pulmonary artery pressure monitor | - | - | - | - | 1件: 86 86 💬
|
238 | Cardiopulmonary evaluation | - | - | - | - | 1件: 13 13 💬
|
239 | Cardiopulmonary exercise testing | - | - | - | - | 1件: 21 21 💬
|
240 | Cardiovascular profile | - | - | - | - | 1件: 113 113 💬
|
241 | Cardura | 1件: Doxazosin Doxazosin | 2件: Doxazosin mesylate
Doxazosin mesylate
,
Doxazosin
💬
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 67 67 💬
|
242 | Care AS usual | - | - | - | - | 1件: 15 15 💬
|
243 | Carfilzomib | 1件: Carfilzomib Carfilzomib | 1件: Carfilzomib
Carfilzomib
💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
244 | Carglumic acid | 1件: Carglumic acid Carglumic acid | 1件: Carglumic acid
Carglumic acid
💬
| 1件: CPS1 CPS1 💬
| 3件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬 | 3件: 245 245, 246, 251 💬
|
245 | Carisbamate | 1件: Carisbamate Carisbamate | 1件: Carisbamate
Carisbamate
💬
| - | - | 1件: 144 144 💬
|
246 | Carisbamate (S)-2-O-carbamoyl-1-O-chlorophenyl-ethanol | 1件: Carisbamate Carisbamate | 1件: Carisbamate
Carisbamate
💬
| - | - | 1件: 144 144 💬
|
247 | Carmustina | 1件: Carmustine Carmustine | 1件: Carmustine
Carmustine
💬
| - | - | 1件: 13 13 💬
|
248 | Carmustine | 1件: Carmustine Carmustine | 1件: Carmustine
Carmustine
💬
| - | - | 5件: 11 11, 13, 14, 28, 60 💬
|
249 | Carnitine | 1件: Levocarnitine Levocarnitine | 2件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | 3件: 46 46, 58, 265 💬
|
250 | Carnosine supplementation | 1件: Carnosine Carnosine | - | - | - | 1件: 6 6 💬
|
251 | Carnosine, capsulle, 2 G/DAY, 8 weeks | 1件: Carnosine Carnosine | - | - | - | 1件: 13 13 💬
|
252 | Carotegrast methyl | 1件: Carotegrast methyl Carotegrast methyl | 1件: Carotegrast methyl
Carotegrast methyl
💬
| 3件: ITGA4 ITGA4, ITGB1, ITGB7 💬
| 30件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagosome, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Transcriptional misregulation in cancer, Virion - Rotavirus, Yersinia infection 💬 | 1件: 97 97 💬
|
253 | CART19 | - | - | - | - | 1件: 49 49 💬
|
254 | Carvedilol | 1件: Carvedilol Carvedilol | 2件: Carvedilol
Carvedilol
,
Carvedilol phosphate
💬
| 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
| 15件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 46, 57, 86, 113, 210 💬
|
255 | Carvi extractum fluidum | - | - | - | - | 1件: 97 97 💬
|
256 | CAS NO.: 7758-16-9 | - | - | - | - | 1件: 166 166 💬
|
257 | Cascade | 1件: Flufenoxuron Flufenoxuron | - | - | - | 1件: 226 226 💬
|
258 | Casein | 1件: Casein Casein | - | - | - | 1件: 97 97 💬
|
259 | Casimersen | 1件: Casimersen Casimersen | 1件: Casimersen
Casimersen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
260 | Caspofungin acetate | 1件: Caspofungin Caspofungin | 2件: Caspofungin acetate
Caspofungin acetate
,
Caspofungin
💬
| - | - | 1件: 60 60 💬
|
261 | CAT-1004 | - | - | - | - | 1件: 113 113 💬
|
262 | CAT-354 | - | - | - | - | 1件: 97 97 💬
|
263 | Catapres ampoules | 1件: Clonidine Clonidine | 2件: Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
264 | Catapresan 75, tabletten | - | - | - | - | 1件: 65 65 💬
|
265 | Cathepsin S | - | - | - | - | 1件: 53 53 💬
|
266 | Cathepsin S inhibitor | - | - | - | - | 1件: 53 53 💬
|
267 | Catheter directed therapy | - | - | - | - | 1件: 88 88 💬
|
268 | Catridecacog | 1件: Catridecacog Catridecacog | 1件: Catridecacog
Catridecacog
💬
| - | - | 2件: 97 97, 288 💬
|
269 | Caudal epidural injection with celestone | - | - | - | - | 1件: 70 70 💬
|
270 | Caudal epidural injection with depomedrol | - | - | - | - | 1件: 70 70 💬
|
271 | Caudal epidural injection with generic celestone | - | - | - | - | 1件: 70 70 💬
|
272 | Cavosonstat | 1件: Cavosonstat Cavosonstat | 1件: Cavosonstat
Cavosonstat
💬
| - | - | 1件: 299 299 💬
|
273 | Cawthorne cooksey exercises | - | - | - | - | 1件: 13 13 💬
|
274 | Cayston | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
275 | Cayston 75 MG pulver UND Lösungsmittel ZUR herstellung einer Lösung FüR einen vernebler | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
276 | Cayston aztreonam 75 MG powder and solvent FOR nebuliser solution | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
277 | CB-01-02 | - | - | - | - | 1件: 97 97 💬
|
278 | CB-01-05-MMX | - | - | - | - | 1件: 97 97 💬
|
279 | CB-010 | 1件: CB-010 CB-010 | - | - | - | 1件: 49 49 💬
|
280 | CB-280 | - | - | - | - | 1件: 299 299 💬
|
281 | CBC | - | - | - | - | 1件: 49 49 💬
|
282 | CBD | - | - | - | - | 9件: 6 6, 8, 13, 36, 140, 144, 145, 156, 158 💬
|
283 | CBD - oral solution, IS known AS epidyolex, and IS THE approved name | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
284 | CBD - solution orale, conosciuto come epidiolex, questo è IL nome approvato negli stati uniti | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
285 | CBD OIL | - | - | - | - | 1件: 51 51 💬
|
286 | CBD oral solution | - | - | - | - | 1件: 206 206 💬
|
287 | CBD oral solution, IS known AS epidyolex and IS THE approved name IN THE EU | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
288 | CBD soluzione orale nota come epidyolex E CON tale nome è stato approvato IN UE | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
289 | CBD, synthetic form | - | - | - | - | 1件: 97 97 💬
|
290 | CBD: GT4 transdermal delivery system | - | - | - | - | 2件: 140 140, 144 💬
|
291 | Cbdca | 1件: Carboplatin Carboplatin | 1件: Carboplatin
Carboplatin
💬
| - | - | 1件: 85 85 💬
|
292 | Cbdv compound | 1件: Cannabidivarin Cannabidivarin | - | - | - | 1件: 193 193 💬
|
293 | CBN | - | - | - | - | 1件: 36 36 💬
|
294 | CBP-307 | - | - | - | - | 1件: 97 97 💬
|
295 | CBT and sleep hygiene | - | - | - | - | 1件: 6 6 💬
|
296 | CBT102-A capsule | - | - | - | - | 1件: 240 240 💬
|
297 | CC-100004 | - | - | - | - | 1件: 84 84 💬
|
298 | CC-10004 | - | - | - | - | 5件: 46 46, 56, 97, 162, 271 💬
|
299 | CC-220 | - | - | - | - | 1件: 49 49 💬
|
300 | CC-220 0.3 MG daily | - | - | - | - | 1件: 84 84 💬
|
301 | CC-220 0.6MG daily | - | - | - | - | 1件: 84 84 💬
|
302 | CC-292 | - | - | - | - | 1件: 46 46 💬
|
303 | CC-4047 | - | - | - | - | 2件: 28 28, 51 💬
|
304 | CC-5013 | - | - | - | - | 2件: 28 28, 96 💬
|
305 | CC-90001 | 1件: CC-90001 CC-90001 | - | - | - | 1件: 85 85 💬
|
306 | CC-930 | - | - | - | - | 1件: 85 85 💬
|
307 | CC-93538 | - | - | - | - | 1件: 98 98 💬
|
308 | CC-97540 | - | - | - | - | 4件: 11 11, 13, 49, 51 💬
|
309 | CC-99677 | - | - | - | - | 1件: 271 271 💬
|
310 | CC-99677 30MG capsule | - | - | - | - | 1件: 271 271 💬
|
311 | CC-99677 60MG capsule | - | - | - | - | 1件: 271 271 💬
|
312 | CC100 | - | - | - | - | 1件: 2 2 💬
|
313 | CC312 | - | - | - | - | 5件: 46 46, 49, 51, 61, 63 💬
|
314 | CCD 1042, MD 9150000, mepalon 1042, SPT316 | - | - | - | - | 2件: 152 152, 206 💬
|
315 | CCD 1042, MD 9150000, mepalon 1042, SPT3162 | - | - | - | - | 1件: 152 152 💬
|
316 | CCI-779 | - | - | - | - | 2件: 13 13, 46 💬
|
317 | CCP-020 | - | - | - | - | 1件: 36 36 💬
|
318 | CCR1 antagonist | - | - | - | - | 1件: 46 46 💬
|
319 | CCX 354-C | - | - | - | - | 1件: 46 46 💬
|
320 | CCX-354-C | 1件: CCX-354 CCX-354 | - | - | - | 1件: 46 46 💬
|
321 | CCX140-B | - | - | - | - | 1件: 222 222 💬
|
322 | CCX168 | - | - | - | - | 6件: 43 43, 44, 49, 66, 109, 222 💬
|
323 | CCX282-B | - | - | - | - | 1件: 96 96 💬
|
324 | CCX354-C | - | - | - | - | 1件: 46 46 💬
|
325 | CD-4 guided therapy interruption | - | - | - | - | 1件: 265 265 💬
|
326 | CD-C-food | - | - | - | - | 1件: 96 96 💬
|
327 | CD-LD CR | - | - | - | - | 1件: 6 6 💬
|
328 | CD-LD IR | - | - | - | - | 1件: 6 6 💬
|
329 | CD19 CAR-T cell infusion | - | - | - | - | 1件: 49 49 💬
|
330 | CD19 CAR-T cells | - | - | - | - | 1件: 49 49 💬
|
331 | CD19 targeted CAR-T cells | - | - | - | - | 3件: 50 50, 51, 53 💬
|
332 | CD19 universal CAR-?D T cells | - | - | - | - | 1件: 49 49 💬
|
333 | CD19 universal CAR-T cells | - | - | - | - | 1件: 49 49 💬
|
334 | CD19- bcma CAR-T cells | - | - | - | - | 4件: 43 43, 49, 51, 53 💬
|
335 | CD19-bcma CAR-T cells infusion | - | - | - | - | 3件: 49 49, 51, 53 💬
|
336 | CD19-bcma targeted CAR-T dose 1 | - | - | - | - | 1件: 11 11 💬
|
337 | CD19-bcma targeted CAR-T dose 2 | - | - | - | - | 1件: 11 11 💬
|
338 | CD19-CAR-DNT cells | - | - | - | - | 2件: 49 49, 51 💬
|
339 | CD19-directed humanised afucosylated monoclonal antibody | - | - | - | - | 1件: 11 11 💬
|
340 | CD19-targetd CAR-T | - | - | - | - | 1件: 50 50 💬
|
341 | CD19/bcma CAR T-cells | - | - | - | - | 2件: 16 16, 61 💬
|
342 | CD19/bcma CAR-T cell therapy | - | - | - | - | 1件: 49 49 💬
|
343 | CD20/BCMA-directed CAR-T cells | - | - | - | - | 3件: 11 11, 13, 49 💬
|
344 | CD3-depleted hematopoietic cell transplantation | - | - | - | - | 1件: 60 60 💬
|
345 | CD3/CD19 depleted leukocytes | - | - | - | - | 1件: 284 284 💬
|
346 | CD3/CD19 NEG allogeneic BMT | - | - | - | - | 1件: 65 65 💬
|
347 | CD3/CD19 negative allogeneic hematopoietic stem cells | - | - | - | - | 1件: 65 65 💬
|
348 | CD3/CD19 negative hematopoietic stem cells | - | - | - | - | 1件: 85 85 💬
|
349 | CD34 selected autologous hematopoietic cells | - | - | - | - | 1件: 51 51 💬
|
350 | CD34 selected haploidentical pbsct | - | - | - | - | 1件: 285 285 💬
|
351 | CD34 stem cell selection therapy | - | - | - | - | 3件: 60 60, 65, 284 💬
|
352 | CD34+ bone marrow stem cells intravitreal | - | - | - | - | 1件: 90 90 💬
|
353 | CD34+ cell enriched stem cell graft | - | - | - | - | 2件: 65 65, 285 💬
|
354 | CD34+ cells | - | - | - | - | 1件: 285 285 💬
|
355 | CD34+ cells enriched with MNV-BLD | - | - | - | - | 1件: 21 21 💬
|
356 | CD34+ enriched, T cell depleted donor stem cell product | - | - | - | - | 1件: 326 326 💬
|
357 | CD34+ hscs transduced with THE lentivirus vector, VSV-G pseudotyped CL20-4I-EF1A-H?C-OPT | - | - | - | - | 1件: 65 65 💬
|
358 | CD34+ peripheral blood stem cell reinfusion | - | - | - | - | 1件: 49 49 💬
|
359 | CD34+ selected cells | - | - | - | - | 1件: 285 285 💬
|
360 | CD34+cells | - | - | - | - | 2件: 65 65, 285 💬
|
361 | CD34+SC | - | - | - | - | 1件: 51 51 💬
|
362 | CD3±CD19 depleted hematopoietic stem cell transplantation | - | - | - | - | 1件: 60 60 💬
|
363 | CD4-IGG | - | - | - | - | 1件: 63 63 💬
|
364 | CD45RA depleted leukocytes | - | - | - | - | 1件: 284 284 💬
|
365 | CD45RA-depleted DLI | - | - | - | - | 1件: 60 60 💬
|
366 | CD62L- TEM | - | - | - | - | 1件: 60 60 💬
|
367 | CD7 CAR T-cells | - | - | - | - | 3件: 50 50, 96, 97 💬
|
368 | CD7 CAR-T cells injection | - | - | - | - | 1件: 60 60 💬
|
369 | Cdca weight-based dose TID | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 263 263 💬
|
370 | Cded (crohn'S disease exclusion diet) IN addition TO ANTI-TNF therapy | - | - | - | - | 2件: 96 96, 97 💬
|
371 | Cded+dairy | - | - | - | - | 1件: 96 96 💬
|
372 | Cded+PEN | - | - | - | - | 1件: 96 96 💬
|
373 | Cdmard | - | - | - | - | 1件: 46 46 💬
|
374 | Cdnf | - | - | - | - | 1件: 6 6 💬
|
375 | CDP 6038 SC | - | - | - | - | 1件: 46 46 💬
|
376 | CDP3194 | - | - | - | - | 1件: 49 49 💬
|
377 | CDP323 | 1件: CDP323 CDP323 | - | - | - | 1件: 13 13 💬
|
378 | CDP6038 | - | - | - | - | 2件: 46 46, 96 💬
|
379 | CDP7657 | - | - | - | - | 1件: 49 49 💬
|
380 | CDP870 | - | - | - | - | 3件: 46 46, 96, 271 💬
|
381 | CDP870 100MG | - | - | - | - | 1件: 46 46 💬
|
382 | CDP870 200MG | - | - | - | - | 1件: 46 46 💬
|
383 | CDP870 400MG | - | - | - | - | 1件: 46 46 💬
|
384 | CDP870 FAB'-PEG | - | - | - | - | 1件: 46 46 💬
|
385 | CDX 6114 | - | - | - | - | 1件: 240 240 💬
|
386 | CDX-0159 | - | - | - | - | 1件: 98 98 💬
|
387 | CDX-1135 | 1件: CDX-1135 CDX-1135 | - | - | - | 1件: 222 222 💬
|
388 | CDZ173 | - | - | - | - | 2件: 53 53, 65 💬
|
389 | CE 224,535 | - | - | - | - | 1件: 46 46 💬
|
390 | CE-224,535 | - | - | - | - | 1件: 46 46 💬
|
391 | CE-VST01-JC | 1件: CE-VST01-JC CE-VST01-JC | - | - | - | 1件: 25 25 💬
|
392 | CE1145 | - | - | - | - | 1件: 65 65 💬
|
393 | Cebion 500*20CPR mast 500MG | - | - | - | - | 1件: 10 10 💬
|
394 | Cebion 500MG 20CPR mast.aran | - | - | - | - | 1件: 10 10 💬
|
395 | Cebsulfase alfa | - | - | - | - | 1件: 19 19 💬
|
396 | Cediranib maleate | 1件: Cediranib Cediranib | 2件: Cediranib
Cediranib
,
Cediranib maleate
💬
| 3件: FLT1 FLT1, FLT4, KDR 💬
| 14件: Breast cancer Breast cancer, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 💬
|
397 | Cefalexin | 1件: Cephalexin Cephalexin | 2件: Cefalexin
Cefalexin
,
Cephalexin
💬
| - | - | 1件: 299 299 💬
|
398 | Cefazolin | 1件: Cefazolin Cefazolin | 2件: Cefazolin sodium
Cefazolin sodium
,
Cefazolin
💬
| - | - | 1件: 291 291 💬
|
399 | Cefazolina qilu | 1件: Cefazolin Cefazolin | 2件: Cefazolin sodium
Cefazolin sodium
,
Cefazolin
💬
| - | - | 1件: 90 90 💬
|
400 | Cefepime dihydrochloride monohydrate | 1件: Cefepime Cefepime | 2件: Cefepime hydrochloride
Cefepime hydrochloride
,
Cefepime
💬
| - | - | 1件: 60 60 💬
|
401 | Cefiderocol | 1件: Cefiderocol Cefiderocol | 2件: Cefiderocol sulfate tosylate
Cefiderocol sulfate tosylate
,
Cefiderocol
💬
| - | - | 1件: 299 299 💬
|
402 | Cefoperazone | 1件: Cefoperazone Cefoperazone | 2件: Cefoperazone sodium
Cefoperazone sodium
,
Cefoperazone
💬
| - | - | 1件: 296 296 💬
|
403 | Ceftaroline | 1件: Ceftaroline fosamil Ceftaroline fosamil | 1件: Ceftaroline fosamil
Ceftaroline fosamil
💬
| - | - | 1件: 299 299 💬
|
404 | Ceftazidim fresenius kabi 2000 MG poeder voor oplossing voor injectie OF infusie | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | 1件: 299 299 💬
|
405 | Ceftazidima pentaidrato | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | 1件: 299 299 💬
|
406 | Ceftazidime | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | 1件: 299 299 💬
|
407 | Ceftazidime and tobramycin | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | 1件: 299 299 💬
|
408 | Ceftazidime pentahydrate | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | 1件: 299 299 💬
|
409 | Ceftazidime/avibactam | 1件: Ceftazidime Ceftazidime | 2件: Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | 1件: 299 299 💬
|
410 | Ceftolozane/tazobactam | 1件: Ceftolozane Ceftolozane | 2件: Ceftolozane
Ceftolozane
,
Ceftolozane sulfate
💬
| - | - | 1件: 299 299 💬
|
411 | Ceftriaxone | 1件: Ceftriaxone Ceftriaxone | 2件: Ceftriaxone sodium
Ceftriaxone sodium
,
Ceftriaxone
💬
| - | - | 3件: 2 2, 6, 97 💬
|
412 | Cefuroxim | 1件: Cefuroxime Cefuroxime | 3件: Cefuroxime
Cefuroxime
,
Cefuroxime axetil
,
Cefuroxime sodium
💬
| - | - | 1件: 299 299 💬
|
413 | Cefuroxima | 1件: Cefuroxime Cefuroxime | 3件: Cefuroxime
Cefuroxime
,
Cefuroxime axetil
,
Cefuroxime sodium
💬
| - | - | 1件: 90 90 💬
|
414 | Cefuroxime | 1件: Cefuroxime Cefuroxime | 3件: Cefuroxime
Cefuroxime
,
Cefuroxime axetil
,
Cefuroxime sodium
💬
| - | - | 2件: 97 97, 299 💬
|
415 | Celebra | - | - | - | - | 1件: 46 46 💬
|
416 | Celebrex | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 46 46, 96, 107, 271 💬
|
417 | Celebrex 200 MG | - | - | - | - | 1件: 46 46 💬
|
418 | Celebrex 200 MG capsule, hard | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
419 | Celebrex 200 MG hartkapseln | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
420 | Celebrex 200MG 20CPS | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
421 | Celebrex 200MG capsule | - | - | - | - | 1件: 70 70 💬
|
422 | Celebrex, celcox | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 2 2 💬
|
423 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 13件: 2 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
424 | Celecoxib 200 milligrams | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
425 | Celecoxib 200MG | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 6 6 💬
|
426 | Celecoxib 200MG capsule | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
427 | Celecoxib 400 milligrams | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 💬
|
428 | Celiac block with triamcinolone and bupivicaine | - | - | - | - | 1件: 298 298 💬
|
429 | Celiprolol | 1件: Celiprolol Celiprolol | 2件: Celiprolol hydrochloride
Celiprolol hydrochloride
,
Celiprolol
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 168 168 💬
|
430 | Cell infusion | - | - | - | - | 3件: 60 60, 62, 283 💬
|
431 | Cell suspension containing dendritic cells | - | - | - | - | 1件: 13 13 💬
|
432 | Cell transplantation | - | - | - | - | 1件: 36 36 💬
|
433 | CELL-based EX-vivo assay with HIGH-content analysis | - | - | - | - | 1件: 41 41 💬
|
434 | CELL-based therapeutics | - | - | - | - | 1件: 2 2 💬
|
435 | CELL-based therapy | - | - | - | - | 1件: 2 2 💬
|
436 | CELL-based therapy OF autologous adipose derived regenerative cells transplanted intraspinally and intrathecally IN ALS patients | - | - | - | - | 1件: 2 2 💬
|
437 | Cellavita HD higher dose | - | - | - | - | 1件: 8 8 💬
|
438 | Cellavita HD lower dose | - | - | - | - | 1件: 8 8 💬
|
439 | Cellavita-HD | - | - | - | - | 1件: 8 8 💬
|
440 | Cellcept | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 5件: 11 11, 13, 42, 43, 49 💬
|
441 | Cellcept 500 MG | - | - | - | - | 1件: 11 11 💬
|
442 | Cellcept 500 MG comprimidos recubiertos | - | - | - | - | 1件: 35 35 💬
|
443 | Cellcept 500 MG FILM-coated tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 11 11 💬
|
444 | Cellcept 500 MG tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 11 11 💬
|
445 | Cellcept® IN autoimmune bullous dermatoses | - | - | - | - | 2件: 35 35, 162 💬
|
446 | Cellcept®500 MG comprimidos | - | - | - | - | 1件: 35 35 💬
|
447 | Cellcept®500 MG tablets | 1件: Mycophenolate mofetil Mycophenolate mofetil | 2件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 11 11 💬
|
448 | Cellular senescence | - | - | - | - | 1件: 46 46 💬
|
449 | Cellular therapy with EBV specific autologous CTL infusion | - | - | - | - | 1件: 13 13 💬
|
450 | Cellule CD34+ autologhe trasdotte CON idua LV codificante PER IL cdna dell'ALFA-L-iduronidasi | - | - | - | - | 1件: 19 19 💬
|
451 | Cellulose | 1件: Microcrystalline cellulose Microcrystalline cellulose | 2件: Microcrystalline cellulose
Microcrystalline cellulose
,
Rayon, purified
💬
| - | - | 1件: 84 84 💬
|
452 | Cellulose acetate with petrolatum | 1件: Microcrystalline cellulose Microcrystalline cellulose | 2件: Microcrystalline cellulose
Microcrystalline cellulose
,
Rayon, purified
💬
| - | - | 2件: 35 35, 162 💬
|
453 | Cellvizio 100 series system with confocal miniprobes | - | - | - | - | 1件: 215 215 💬
|
454 | Celulas hepatocitos troncales adultas alogenicas DE higado expandidas | - | - | - | - | 1件: 251 251 💬
|
455 | Celulas madre mesenquimales troncales adultas alogenicas DE Médula óSEA NO expandida | - | - | - | - | 1件: 274 274 💬
|
456 | Cemdisiran | 1件: Cemdisiran Cemdisiran | - | - | - | 4件: 11 11, 62, 66, 109 💬
|
457 | Cendakimab | 1件: Cendakimab Cendakimab | 1件: Cendakimab
Cendakimab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 98 98 💬
|
458 | Cenegermin | 1件: Cenegermin Cenegermin | 1件: Cenegermin
Cenegermin
💬
| 1件: NGFR NGFR 💬
| 9件: Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | 1件: 53 53 💬
|
459 | Cenerimod | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
460 | Cenerimod 0.5 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
461 | Cenerimod 1 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
462 | Cenerimod 2 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
463 | Cenerimod 4 MG | 1件: Cenerimod Cenerimod | 1件: Cenerimod
Cenerimod
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 49 49 💬
|
464 | Cenicriviroc 150 MG | 1件: Cenicriviroc Cenicriviroc | 2件: Cenicriviroc
Cenicriviroc
,
Cenicriviroc mesylate
💬
| 2件: CCR2 CCR2, CCR5 💬
| 11件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 1件: 94 94 💬
|
465 | Cenplacel-L | 1件: Cenplacel-L Cenplacel-L | 1件: Cenplacel-L
Cenplacel-L
💬
| - | - | 1件: 84 84 💬
|
466 | Censavudine | 1件: Censavudine Censavudine | 1件: Censavudine
Censavudine
💬
| - | - | 3件: 2 2, 127, 325 💬
|
467 | Centerpiece titanium plate | - | - | - | - | 1件: 70 70 💬
|
468 | Centricyte 1000 | - | - | - | - | 2件: 85 85, 229 💬
|
469 | CEP-1347 10MG | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 💬
|
470 | CEP-1347 50MG | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 💬
|
471 | CEP-33457 | - | - | - | - | 1件: 49 49 💬
|
472 | CEP1347 25MG | - | - | - | - | 1件: 6 6 💬
|
473 | Cephalexin | 1件: Cephalexin Cephalexin | 2件: Cefalexin
Cefalexin
,
Cephalexin
💬
| - | - | 1件: 299 299 💬
|
474 | Cepharanthin | 1件: Cepharanthine Cepharanthine | 1件: Cepharanthine
Cepharanthine
💬
| - | - | 1件: 53 53 💬
|
475 | Cepharanthine | 1件: Cepharanthine Cepharanthine | 1件: Cepharanthine
Cepharanthine
💬
| - | - | 1件: 53 53 💬
|
476 | CER-001 | 1件: CER-001 CER-001 | - | - | - | 1件: 79 79 💬
|
477 | Ceralifimod | 1件: Ceralifimod Ceralifimod | - | - | - | 1件: 13 13 💬
|
478 | Ceralifmod | - | - | - | - | 1件: 13 13 💬
|
479 | Ceramic ON ceramic articulation | - | - | - | - | 1件: 46 46 💬
|
480 | Ceramic ON polyethylene articulation | - | - | - | - | 1件: 46 46 💬
|
481 | Cerazette | - | - | - | - | 1件: 230 230 💬
|
482 | CERC-006 | - | - | - | - | 1件: 278 278 💬
|
483 | Cerdelga | 1件: Eliglustat Eliglustat | 2件: Eliglustat
Eliglustat
,
Eliglustat tartrate
💬
| 1件: UGCG UGCG 💬
| 2件: Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
484 | CERE-120 | 1件: CERE-120 CERE-120 | - | - | - | 1件: 6 6 💬
|
485 | CERE-120: AAV2-NTN | 1件: CERE-120 CERE-120 | - | - | - | 1件: 6 6 💬
|
486 | CERE-120: adeno-associated virus delivery OF neurturin | 1件: CERE-120 CERE-120 | - | - | - | 1件: 6 6 💬
|
487 | Cerebral dopamine neurotrophic factor | 1件: HER-902 HER-902 | - | - | - | 1件: 6 6 💬
|
488 | Cerebro-spinal fluid | - | - | - | - | 1件: 13 13 💬
|
489 | Cerebrolysin | 1件: Cerebrolysin Cerebrolysin | - | - | - | 1件: 124 124 💬
|
490 | Ceretec (TM) estabilizado | - | - | - | - | 1件: 6 6 💬
|
491 | Cerezyme | 1件: Imiglucerase Imiglucerase | 2件: Alglucerase
Alglucerase
,
Imiglucerase
💬
| 1件: GBA GBA 💬
| 4件: Cornified envelope formation Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
492 | Cerezyme 400 units powder FOR concentrate FOR solution FOR infusion | 1件: Imiglucerase Imiglucerase | 2件: Alglucerase
Alglucerase
,
Imiglucerase
💬
| 1件: GBA GBA 💬
| 4件: Cornified envelope formation Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
493 | Cerezyme 400 unità polvere PER concentrato PER soluzione PER infusione | - | - | - | - | 1件: 19 19 💬
|
494 | Cerezyme® / imiglucerase | 1件: Imiglucerase Imiglucerase | 2件: Alglucerase
Alglucerase
,
Imiglucerase
💬
| 1件: GBA GBA 💬
| 4件: Cornified envelope formation Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
495 | Cerliponase alfa | 1件: Cerliponase alfa Cerliponase alfa | 1件: Cerliponase alfa
Cerliponase alfa
💬
| 1件: TPP1 TPP1 💬
| 1件: Lysosome Lysosome 💬 | 1件: 19 19 💬
|
496 | Certican | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 3件: 67 67, 96, 228 💬
|
497 | Certican 0,5 MG tabletten | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 228 228 💬
|
498 | Certican 0,75MG tabletten | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 228 228 💬
|
499 | Certican 1 MG tablets | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 158 158 💬
|
500 | Certican tabletten | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 67 67 💬
|
501 | Certolizumab | - | - | - | - | 4件: 46 46, 96, 270, 271 💬
|
502 | Certolizumab pegol | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 7件: 37 37, 46, 49, 96, 107, 226, 271 💬
|
503 | Certolizumab pegol (CZP) 200 MG | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
504 | Certolizumab pegol (CZP) 400 MG | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
505 | Certolizumab pegol / cimzia | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
506 | Certolizumab pegol /cimzia | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
507 | Certolizumab pegol 400 MG | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
508 | Certolizumabpegol injection | - | - | - | - | 1件: 46 46 💬
|
509 | Certoluzimab pegol | - | - | - | - | 1件: 46 46 💬
|
510 | Cervarix suspensie voor injectie | - | - | - | - | 3件: 49 49, 50, 107 💬
|
511 | Cervical interbody fusion | - | - | - | - | 1件: 70 70 💬
|
512 | Ceterizine | - | - | - | - | 1件: 13 13 💬
|
513 | Cetirizina | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 300 300, 309 💬
|
514 | Cetirizina dicloridrato | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 💬
|
515 | Cetirizina mylan generics | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
516 | Cetirizine | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 3件: 13 13, 19, 35 💬
|
517 | Cetirizine hydrochloride | 1件: Cetirizine Cetirizine | 2件: Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
518 | Cetrizine | - | - | - | - | 1件: 13 13 💬
|
519 | Cetrorelix | 1件: Cetrorelix Cetrorelix | 2件: Cetrorelix acetate
Cetrorelix acetate
,
Cetrorelix
💬
| 1件: GNRHR GNRHR 💬
| 3件: GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 💬
|
520 | Cetuximab | 1件: Cetuximab Cetuximab | 1件: Cetuximab
Cetuximab
💬
| 1件: EGFR EGFR 💬
| 47件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬 | 5件: 34 34, 51, 86, 89, 331 💬
|
521 | Cevidoplenib | 1件: Cevidoplenib Cevidoplenib | - | - | - | 1件: 46 46 💬
|
522 | Cevimeline | 1件: Cevimeline Cevimeline | 2件: Cevimeline hydrochloride
Cevimeline hydrochloride
,
Cevimeline
💬
| 1件: CHRM3 CHRM3 💬
| 12件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 53 53 💬
|
523 | CF fatalism scale | - | - | - | - | 1件: 299 299 💬
|
524 | CF patients with A G551D mutation and treated with ivacaftor | - | - | - | - | 1件: 299 299 💬
|
525 | CF101 | - | - | - | - | 1件: 46 46 💬
|
526 | CF101 1 MG | - | - | - | - | 1件: 46 46 💬
|
527 | CF101 2 MG | - | - | - | - | 1件: 46 46 💬
|
528 | Cftr modulators | - | - | - | - | 1件: 299 299 💬
|
529 | Cftr potentiator | - | - | - | - | 1件: 299 299 💬
|
530 | CFZ533 | - | - | - | - | 4件: 11 11, 46, 49, 53 💬
|
531 | CFZ533 active - cohort 1 | - | - | - | - | 1件: 53 53 💬
|
532 | CFZ533 active - cohort 2 | - | - | - | - | 1件: 53 53 💬
|
533 | CFZ533 active - cohort 3 | - | - | - | - | 1件: 53 53 💬
|
534 | CFZ533 active -cohort 3 | - | - | - | - | 1件: 53 53 💬
|
535 | CGM/CKM | - | - | - | - | 1件: 67 67 💬
|
536 | Cgmp protein | - | - | - | - | 1件: 97 97 💬
|
537 | CGP 77116 | - | - | - | - | 1件: 13 13 💬
|
538 | CH-1504 | - | - | - | - | 1件: 46 46 💬
|
539 | CH-4051 | - | - | - | - | 1件: 46 46 💬
|
540 | Chadox1 NCOV-19 | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 3件: 46 46, 51, 299 💬
|
541 | Chadox2 HAV | - | - | - | - | 1件: 96 96 💬
|
542 | Challenge agent: capsaicin | - | - | - | - | 1件: 19 19 💬
|
543 | Champix | 1件: Varenicline Varenicline | 2件: Varenicline tartrate
Varenicline tartrate
,
Varenicline
💬
| 2件: CHRNA4 CHRNA4, CHRNB2 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 1件: 6 6 💬
|
544 | Characterization, evaluation and comparison OF macular pigment density | - | - | - | - | 1件: 264 264 💬
|
545 | Charcoal | - | - | - | - | 1件: 13 13 💬
|
546 | Chelation | - | - | - | - | 1件: 60 60 💬
|
547 | Chemically modified recombinant human sulfamidase | - | - | - | - | 1件: 19 19 💬
|
548 | Chemotherapy | - | - | - | - | 3件: 28 28, 60, 285 💬
|
549 | Chemotherapy agents | - | - | - | - | 1件: 51 51 💬
|
550 | Chemotherapy, intrathecal chemotherapy, steroid therapy | - | - | - | - | 1件: 65 65 💬
|
551 | Chenodeoxycholic acid | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 4件: 20 20, 96, 234, 263 💬
|
552 | Chenodeoxycholic acid leadiant | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 263 263 💬
|
553 | Chenodiol | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 96 96 💬
|
554 | Chenofalk | - | - | - | - | 1件: 96 96 💬
|
555 | CHF 6333 | - | - | - | - | 1件: 299 299 💬
|
556 | CHF10067 high dose | - | - | - | - | 1件: 85 85 💬
|
557 | CHF10067 intermediate dose | - | - | - | - | 1件: 85 85 💬
|
558 | CHF10067 starting dose | - | - | - | - | 1件: 85 85 💬
|
559 | CHF6333 | - | - | - | - | 1件: 299 299 💬
|
560 | CHF6657 | - | - | - | - | 1件: 19 19 💬
|
561 | Chicken type II collagen | 1件: Chicken Chicken | - | - | - | 1件: 46 46 💬
|
562 | Childhood health assessment questionnaire | - | - | - | - | 1件: 50 50 💬
|
563 | Chimeric fibril-reactive IGG1K monoclonal antibody 11-1f4 | - | - | - | - | 1件: 28 28 💬
|
564 | Chimeric fibril-reactive monoclonal ANTI-body 11-1f4 | - | - | - | - | 1件: 28 28 💬
|
565 | Chimeric human-murine IGG1 | - | - | - | - | 1件: 46 46 💬
|
566 | Chimeric human/mouse ANTI-CD-20 monoclonal antibody | - | - | - | - | 1件: 46 46 💬
|
567 | Chimeric IGG1 monoclonal antibody | - | - | - | - | 1件: 96 96 💬
|
568 | Chimeric monoclonal antibody, IGG4 subtype | - | - | - | - | 2件: 43 43, 44 💬
|
569 | Chimeric murine human ANTI-IL-6 monoclonal antibody | - | - | - | - | 1件: 331 331 💬
|
570 | Chinese herb prescription granule plus prednisone | - | - | - | - | 1件: 66 66 💬
|
571 | Chinese herbal concoction twice A DAY FOR 6 months | - | - | - | - | 1件: 60 60 💬
|
572 | Chinese herbal medicine treatment | - | - | - | - | 1件: 6 6 💬
|
573 | Chinese herbal TEA tbdesjs | - | - | - | - | 1件: 53 53 💬
|
574 | Chinese herbs based ON syndrome differentiation | - | - | - | - | 1件: 224 224 💬
|
575 | Chlorhexidine | 1件: Chlorhexidine Chlorhexidine | 4件: Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
💬
| - | - | 1件: 86 86 💬
|
576 | Chlorhexidine gluconate | 1件: Chlorhexidine Chlorhexidine | 4件: Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
💬
| - | - | 1件: 299 299 💬
|
577 | Chlorhexidine gluconate oral rinse | 1件: Chlorhexidine Chlorhexidine | 4件: Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
💬
| - | - | 1件: 299 299 💬
|
578 | Chloride | 1件: Chloride ion Chloride ion | - | - | - | 1件: 97 97 💬
|
579 | Chlorogenic acid | 1件: Chlorogenic Acid Chlorogenic Acid | - | - | - | 1件: 97 97 💬
|
580 | Chloroquine | 1件: Chloroquine Chloroquine | 4件: Chloroquine phosphate
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
💬
| - | - | 1件: 46 46 💬
|
581 | Chloroquine diphosphate | 1件: Chloroquine Chloroquine | 4件: Chloroquine phosphate
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
💬
| - | - | 1件: 95 95 💬
|
582 | Chloroquine diphosphate 250MG | 1件: Chloroquine Chloroquine | 4件: Chloroquine phosphate
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
💬
| - | - | 1件: 95 95 💬
|
583 | Chlorothiazide | 1件: Chlorothiazide Chlorothiazide | 2件: Chlorothiazide
Chlorothiazide
,
Chlorothiazide sodium
💬
| 1件: SLC12A3 SLC12A3 💬
| 1件: Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | 1件: 225 225 💬
|
584 | Chlorpromazine hydrochloride | 1件: Chlorpromazine Chlorpromazine | 2件: Chlorpromazine
Chlorpromazine
,
Chlorpromazine hydrochloride
💬
| 13件: ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2, HTR2, HTR2 💬
| 24件: Alcoholism Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 254 254 💬
|
585 | Chlorure DE sodium | - | - | - | - | 1件: 96 96 💬
|
586 | Chocolate | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 💬
|
587 | Cholecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
|
588 | Cholecalciferol 10,000 IU | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
589 | Cholecalciferol 400 IU | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
590 | Cholecalciferol and C. xanthorrhiza | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 49 49 💬
|
591 | Cholecalciferol concentrate | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
592 | Cholecalciferol pill | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 💬
|
593 | Cholecalciferol, vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 13 13 💬
|
594 | Cholestagel | 1件: Colesevelam Colesevelam | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | 2件: 79 79, 96 💬
|
595 | Cholesterol | 1件: Cholesterol Cholesterol | 1件: Cholesterol
Cholesterol
💬
| - | - | 5件: 19 19, 90, 160, 222, 310 💬
|
596 | Cholesterol supplementation | 1件: Cholesterol Cholesterol | 1件: Cholesterol
Cholesterol
💬
| - | - | 1件: 310 310 💬
|
597 | Cholesterol suspension | 1件: Cholesterol Cholesterol | 1件: Cholesterol
Cholesterol
💬
| - | - | 1件: 310 310 💬
|
598 | Cholestyramine | 1件: Cholestyramine Cholestyramine | 1件: Cholestyramine resin
Cholestyramine resin
💬
| - | - | 2件: 13 13, 79 💬
|
599 | Cholic acid | 1件: Cholic Acid Cholic Acid | 1件: Cholic acid
Cholic acid
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 4件: 20 20, 234, 265, 310 💬
|
600 | Cholic acids | - | - | - | - | 2件: 20 20, 234 💬
|
601 | Choline chloride | 1件: Choline Choline | 1件: Choline
Choline
💬
| - | - | 1件: 299 299 💬
|
602 | Choline supplementation | 1件: Choline Choline | 1件: Choline
Choline
💬
| - | - | 1件: 299 299 💬
|
603 | Chondroitin sulfate | 1件: Chondroitin sulfate Chondroitin sulfate | 1件: Chondroitin sulfate A
Chondroitin sulfate A
💬
| - | - | 1件: 96 96 💬
|
604 | Chong KUN dang tofacitinib tablet | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 💬
|
605 | CHOP-daclizumab | - | - | - | - | 1件: 26 26 💬
|
606 | CHQ | - | - | - | - | 1件: 50 50 💬
|
607 | CHR-1103 / GBR500 | - | - | - | - | 1件: 13 13 💬
|
608 | Chromium | 1件: Chromium Chromium | - | - | - | 1件: 46 46 💬
|
609 | Chronic antioxidant | - | - | - | - | 1件: 299 299 💬
|
610 | Chronic corticosteroid therapy | - | - | - | - | 1件: 113 113 💬
|
611 | Chronic- PF-06480605 150 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
612 | Chronic- PF-06480605 450 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
613 | Chronic- PF-06480605 50 MG SC Q4W | - | - | - | - | 1件: 97 97 💬
|
614 | Chronocort | - | - | - | - | 1件: 81 81 💬
|
615 | Chronocort 10MG | - | - | - | - | 1件: 81 81 💬
|
616 | Chronocort 5MG | - | - | - | - | 1件: 81 81 💬
|
617 | Chronocort® 10 MG | - | - | - | - | 1件: 81 81 💬
|
618 | Chronocort® 20 MG | - | - | - | - | 1件: 81 81 💬
|
619 | Chronocort® 5 MG | - | - | - | - | 1件: 81 81 💬
|
620 | CHS-0214 | - | - | - | - | 1件: 46 46 💬
|
621 | Chuna manipulation | - | - | - | - | 1件: 70 70 💬
|
622 | Chuna manual medicine | - | - | - | - | 1件: 70 70 💬
|
623 | CHX A-dtpa ANTI-CD66 antibody | - | - | - | - | 1件: 28 28 💬
|
624 | CHX-A-DTPA-ANTI-CD66 | - | - | - | - | 1件: 28 28 💬
|
625 | CI-984 | - | - | - | - | 1件: 75 75 💬
|
626 | CI-984, 17aa70, PD 132301-2 | - | - | - | - | 1件: 81 81 💬
|
627 | Cialis | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 86 💬
|
628 | Cialis - 20 MG 2 compresse rivestite CON film IN blister USO orale | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 75 75, 77 💬
|
629 | Cialis 10 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
630 | Cialis 2.5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
631 | Cialis 20 MG comprimidos recubiertos CON PELícula | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
632 | Cialis 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
633 | Cialis 5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
634 | Cianocobalamina | 1件: Cyanocobalamin Cyanocobalamin | 5件: Cyanocobalamin
Cyanocobalamin
,
Vitamin B12
,
Cyanocobalamin Co 57
,
Cyanocobalamin Co 58
,
Cyanocobalamin Co 60
💬
| - | - | 1件: 13 13 💬
|
635 | CIC | - | - | - | - | 1件: 118 118 💬
|
636 | CIC using lofric primo | - | - | - | - | 1件: 13 13 💬
|
637 | Ciclesonide | 1件: Ciclesonide Ciclesonide | 1件: Ciclesonide
Ciclesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬
|
638 | Cicletanine | 1件: Cicletanine Cicletanine | 2件: Cicletanine
Cicletanine
,
Cicletanine hydrochloride
💬
| - | - | 1件: 86 86 💬
|
639 | Cicletanine hydrochloride | 1件: Cicletanine Cicletanine | 2件: Cicletanine
Cicletanine
,
Cicletanine hydrochloride
💬
| - | - | 1件: 86 86 💬
|
640 | Ciclofosfamida | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 222 222 💬
|
641 | Ciclofosfamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 49 49, 51 💬
|
642 | Ciclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 12件: 26 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 269 💬
|
643 | Ciclosporin A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
644 | Ciclosporin soft capsule | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬
|
645 | Ciclosporin soft capsules | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
646 | Ciclosporina | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 49 49, 60, 97 💬
|
647 | Ciclosporina / ciclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
648 | Ciclosporina A liposomica aerolised liposomal ciclosporin A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
649 | Ciclosporina/ ciclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
650 | Ciclosporine | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 60 60 💬
|
651 | Ciclosporine A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
652 | Ciclosporine, ciclosporina | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
653 | Cidofovir | 1件: Cidofovir Cidofovir | 1件: Cidofovir
Cidofovir
💬
| - | - | 1件: 25 25 💬
|
654 | Ciklosporin | - | - | - | - | 1件: 226 226 💬
|
655 | Cilastatin | 1件: Cilastatin Cilastatin | 2件: Cilastatin sodium
Cilastatin sodium
,
Cilastatin
💬
| - | - | 1件: 60 60 💬
|
656 | Cilazapril | 1件: Cilazapril Cilazapril | 2件: Cilazapril
Cilazapril
,
Cilazapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 66 66 💬
|
657 | Ciliary neurotrophic factor implant NT-501 | 1件: Ciliary neurotrophic factor Ciliary neurotrophic factor | - | - | - | 1件: 90 90 💬
|
658 | Cilnidipine | 1件: Cilnidipine Cilnidipine | 1件: Cilnidipine
Cilnidipine
💬
| 5件: CACNA1B CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 41件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Nicotine addiction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 67 67 💬
|
659 | Cilo | - | - | - | - | 1件: 94 94 💬
|
660 | Cilofexor | 1件: Cilofexor Cilofexor | - | - | - | 2件: 93 93, 94 💬
|
661 | Cilostazol | 1件: Cilostazol Cilostazol | 1件: Cilostazol
Cilostazol
💬
| 3件: PDE3A PDE3A, PDE3B, TBXA2R 💬
| 13件: Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 46, 51, 70, 124 💬
|
662 | Cilostazol 100 MG | 1件: Cilostazol Cilostazol | 1件: Cilostazol
Cilostazol
💬
| 3件: PDE3A PDE3A, PDE3B, TBXA2R 💬
| 13件: Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬
|
663 | Ciltacabtagene autoleucel | 1件: Ciltacabtagene autoleucel Ciltacabtagene autoleucel | 1件: Ciltacabtagene autoleucel
Ciltacabtagene autoleucel
💬
| 2件: CD38 CD38, TNFRSF17 💬
| 8件: Calcium signaling pathway Calcium signaling pathway, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 💬
|
664 | Cimetidine | 1件: Cimetidine Cimetidine | 2件: Cimetidine
Cimetidine
,
Cimetidine hydrochloride
💬
| 1件: HRH2 HRH2 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 254 254 💬
|
665 | Cimetidine plus dexpramipexole | 2件: Cimetidine Cimetidine, Dexpramipexole | 3件: Cimetidine
Cimetidine
,
Cimetidine hydrochloride
,
Dexpramipexole
💬
| 6件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, HRH2 💬
| 14件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
666 | Cimzia | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 6件: 46 46, 49, 96, 97, 107, 271 💬
|
667 | Cimzia 200 MG injeksjonsvæSKE, oppløsning | - | - | - | - | 1件: 46 46 💬
|
668 | Cimzia 200 MG solution FOR injection | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 271 💬
|
669 | Cimzia certolizumab pegol 200 MG/ML solution FOR injection | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
670 | Cinacalcet | 1件: Cinacalcet Cinacalcet | 2件: Cinacalcet
Cinacalcet
,
Cinacalcet hydrochloride
💬
| 1件: CASR CASR 💬
| 2件: NOD-like receptor signaling pathway NOD-like receptor signaling pathway, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 238 238 💬
|
671 | Cinryze | - | - | - | - | 1件: 65 65 💬
|
672 | Cinryze 1000 | - | - | - | - | 1件: 65 65 💬
|
673 | Cinryze 1000 U | - | - | - | - | 1件: 65 65 💬
|
674 | Cinryze 500 | - | - | - | - | 1件: 65 65 💬
|
675 | Cinryze 500 U | - | - | - | - | 1件: 65 65 💬
|
676 | Cinryze with rhuph20 | - | - | - | - | 1件: 65 65 💬
|
677 | Cipaglucosidase alfa | 1件: Cipaglucosidase alfa Cipaglucosidase alfa | 1件: Cipaglucosidase alfa
Cipaglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
678 | Cipaglucosidasi alfa | - | - | - | - | 1件: 256 256 💬
|
679 | Cipralex | - | - | - | - | 1件: 6 6 💬
|
680 | Cipro inhale | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 299 299 💬
|
681 | Cipro, ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 2 2 💬
|
682 | Ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 6件: 2 2, 46, 60, 96, 97, 299 💬
|
683 | Ciprofloxacin (BAYQ3939) DRY powder FOR inhalation | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 299 299 💬
|
684 | Ciprofloxacin dispersion FOR inhalation | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 299 299 💬
|
685 | Ciprofloxacin DPI | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 299 299 💬
|
686 | Ciprofloxacin FOR inhalation | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 299 299 💬
|
687 | Ciprofloxacin hydrochloride | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 2件: 96 96, 299 💬
|
688 | Ciprofloxacin hydrochloride monohydrate | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 299 299 💬
|
689 | Ciprofloxacin inhale | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 1件: 299 299 💬
|
690 | Ciprofloxacina cloridrato | - | - | - | - | 2件: 2 2, 299 💬
|
691 | Ciproxin | - | - | - | - | 1件: 299 299 💬
|
692 | Ciproxin suspension | - | - | - | - | 1件: 299 299 💬
|
693 | Ciproxin*6CPR RIV 500MG | - | - | - | - | 1件: 299 299 💬
|
694 | Circadian rhythm measurement | - | - | - | - | 1件: 106 106 💬
|
695 | Circadin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
696 | Circadin 2 MG comprimidos DE liberacióN prolongada | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 💬
|
697 | CIS-4-hydroxy-L-proline | - | - | - | - | 1件: 94 94 💬
|
698 | Cisapride | 1件: Cisapride Cisapride | 2件: Cisapride
Cisapride
,
Cisapride
💬
| 3件: HTR2 HTR2, HTR3, HTR4 💬
| 8件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
699 | Cisplatin | 1件: Cisplatin Cisplatin | 1件: Cisplatin
Cisplatin
💬
| - | - | 1件: 28 28 💬
|
700 | Cistanche total glycosides | - | - | - | - | 1件: 2 2 💬
|
701 | CIT-013 high dose | - | - | - | - | 1件: 46 46 💬
|
702 | CIT-013 LOW dose | - | - | - | - | 1件: 46 46 💬
|
703 | Citalopram | 1件: Citalopram Citalopram | 2件: Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 46, 98, 127 💬
|
704 | Citalopram 20MG | 1件: Citalopram Citalopram | 2件: Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| 1件: SLC6A4 SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 💬
|
705 | Citarabina | 1件: Cytarabine Cytarabine | 2件: Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | 1件: 13 13 💬
|
706 | Citicolin*1G/4ML IM IV 5 F | - | - | - | - | 1件: 6 6 💬
|
707 | Citicolina 1000 MG/DIE | 1件: Citicoline Citicoline | 2件: Citicoline
Citicoline
,
Citicoline sodium
💬
| - | - | 1件: 6 6 💬
|
708 | Citicolina sodica | 1件: Citicoline Citicoline | 2件: Citicoline
Citicoline
,
Citicoline sodium
💬
| - | - | 1件: 6 6 💬
|
709 | Citochine ED immunomodulatori | - | - | - | - | 1件: 13 13 💬
|
710 | Citocoline | - | - | - | - | 1件: 205 205 💬
|
711 | Citric acid | 1件: Citric acid Citric acid | 2件: Citric acid, anhydrous
Citric acid, anhydrous
,
Citric acid monohydrate
💬
| - | - | 1件: 53 53 💬
|
712 | Citric acid based mouthwash | 1件: Citric acid Citric acid | 2件: Citric acid, anhydrous
Citric acid, anhydrous
,
Citric acid monohydrate
💬
| - | - | 1件: 53 53 💬
|
713 | Citrulline | 1件: Citrulline Citrulline | 2件: L-Citrulline
L-Citrulline
,
Citrulline malate
💬
| - | - | 1件: 113 113 💬
|
714 | CK-2017357 | - | - | - | - | 1件: 2 2 💬
|
715 | CK-2127107 | 1件: Reldesemtiv Reldesemtiv | 1件: Reldesemtiv
Reldesemtiv
💬
| 3件: TNNC2 TNNC2, TNNI2, TNNT3 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 2 2 💬
|
716 | CK-3773274 | - | - | - | - | 1件: 58 58 💬
|
717 | CK-3773274 - granules IN capsule | - | - | - | - | 1件: 58 58 💬
|
718 | CK-3773274 - tablets | - | - | - | - | 1件: 58 58 💬
|
719 | CK0803 | - | - | - | - | 1件: 2 2 💬
|
720 | CK2017357 | - | - | - | - | 1件: 2 2 💬
|
721 | CKD-504 | 1件: CKD-504 CKD-504 | - | - | - | 1件: 8 8 💬
|
722 | CKD-506 | - | - | - | - | 1件: 46 46 💬
|
723 | CL20-I4-EF1A-H?C-OPT | - | - | - | - | 1件: 65 65 💬
|
724 | CLA | - | - | - | - | 2件: 13 13, 97 💬
|
725 | Cladribina | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
726 | Cladribina oral | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
727 | Cladribine | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 3件: 11 11, 13, 94 💬
|
728 | Cladribine 10 MG oral tablet | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
729 | Cladribine 3.5 MG/KG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
730 | Cladribine 5.25 MG/KG | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
731 | Cladribine high dose | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 11 11 💬
|
732 | Cladribine LOW dose | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 11 11 💬
|
733 | Cladribine oral tablet | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
734 | Cladribine pill | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
735 | Cladribine subcutaneous injection | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
736 | Cladribine tablet | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
737 | Cladribine tablets | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
738 | Cladrybine | - | - | - | - | 1件: 11 11 💬
|
739 | Clarithromycin | 1件: Clarithromycin Clarithromycin | 1件: Clarithromycin
Clarithromycin
💬
| - | - | 8件: 6 6, 46, 63, 84, 96, 97, 228, 299 💬
|
740 | Claritromycin 500MG film coated tablets | - | - | - | - | 1件: 299 299 💬
|
741 | Clarium 50 MG retardtabletten | - | - | - | - | 1件: 6 6 💬
|
742 | Clarix FLO | - | - | - | - | 1件: 226 226 💬
|
743 | Clartihromycin, amoxicillin, and omeprazole | - | - | - | - | 1件: 6 6 💬
|
744 | Classic dmards treatment group | - | - | - | - | 1件: 46 46 💬
|
745 | Classic, progressive endurance training | - | - | - | - | 1件: 13 13 💬
|
746 | Classical ketogenic diet | - | - | - | - | 1件: 137 137 💬
|
747 | Clasteon | - | - | - | - | 1件: 274 274 💬
|
748 | Clavulanic acid | 1件: Clavulanic acid Clavulanic acid | 2件: Clavulanate potassium
Clavulanate potassium
,
Clavulanic acid
💬
| - | - | 1件: 299 299 💬
|
749 | Clazakizumab | 1件: Clazakizumab Clazakizumab | 1件: Clazakizumab
Clazakizumab
💬
| - | - | 1件: 46 46 💬
|
750 | CLBS12 | 1件: CLBS12 CLBS12 | - | - | - | 1件: 47 47 💬
|
751 | CLE | - | - | - | - | 1件: 6 6 💬
|
752 | Clemastine | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
753 | Clemastine fumarate | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
754 | Clemastine fumarate tablets | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 179 179 💬
|
755 | Clemastine milstein 1 MG, tabletten | 1件: Clemastine Clemastine | 2件: Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 💬
|
756 | Clemizole HCL | 1件: Clemizole Clemizole | 2件: Clemizole hydrochloride
Clemizole hydrochloride
,
Clemizole
💬
| 1件: TRPC5 TRPC5 💬
| 2件: Axon guidance Axon guidance, GnRH secretion 💬 | 2件: 140 140, 144 💬
|
757 | Clemizole hydrochloride | 1件: Clemizole Clemizole | 2件: Clemizole hydrochloride
Clemizole hydrochloride
,
Clemizole
💬
| 1件: TRPC5 TRPC5 💬
| 2件: Axon guidance Axon guidance, GnRH secretion 💬 | 1件: 140 140 💬
|
758 | Clenbuterol | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 1 1, 2, 113, 256 💬
|
759 | Clenbuterol HCL | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
760 | Clenbuterol hydrochloride | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
761 | Clenbuterolo | - | - | - | - | 1件: 1 1 💬
|
762 | Clervonafusp alfa | 1件: Clervonafusp alfa Clervonafusp alfa | 1件: Clervonafusp alfa
Clervonafusp alfa
💬
| 2件: GAA GAA, SLC29A1_2_3 💬
| 4件: Alcoholism Alcoholism, Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 309 309 💬
|
763 | Clindamycin | 1件: Clindamycin Clindamycin | 4件: Clindamycin
Clindamycin
,
Clindamycin phosphate
,
Clindamycin palmitate hydrochloride
,
Clindamycin hydrochloride
💬
| - | - | 2件: 46 46, 299 💬
|
764 | Clinical and neurological evaluation | - | - | - | - | 1件: 13 13 💬
|
765 | Clinical and neuropsychological assessments | - | - | - | - | 1件: 6 6 💬
|
766 | Clinical assessment | - | - | - | - | 2件: 6 6, 13 💬
|
767 | Clinical characteristics OF AMS patients | - | - | - | - | 1件: 17 17 💬
|
768 | Clinical DBS setting | - | - | - | - | 1件: 6 6 💬
|
769 | Clinical foot evaluation | - | - | - | - | 1件: 46 46 💬
|
770 | Clinical laboratory evaluations - biochemistry | - | - | - | - | 1件: 49 49 💬
|
771 | Clinical laboratory evaluations - hematology | - | - | - | - | 1件: 49 49 💬
|
772 | Clinical laboratory evaluations - serology | - | - | - | - | 1件: 49 49 💬
|
773 | Clinical observation | - | - | - | - | 1件: 205 205 💬
|
774 | Clinican CBD 10% OIL | - | - | - | - | 1件: 13 13 💬
|
775 | Clinimacs | - | - | - | - | 2件: 60 60, 65 💬
|
776 | Clinimacs device | - | - | - | - | 2件: 60 60, 285 💬
|
777 | Clinimacs prodigy system | - | - | - | - | 1件: 285 285 💬
|
778 | Clinimacs® TCR A/ß reagent KIT and clinimacs® CD19 system | - | - | - | - | 3件: 19 19, 96, 222 💬
|
779 | Clipper | - | - | - | - | 1件: 97 97 💬
|
780 | CLN-978 | - | - | - | - | 1件: 49 49 💬
|
781 | Clobazam | 1件: Clobazam Clobazam | 1件: Clobazam
Clobazam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 140 140, 144 💬
|
782 | Clobazam high dose | 1件: Clobazam Clobazam | 1件: Clobazam
Clobazam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 💬
|
783 | Clobazam LOW dose | 1件: Clobazam Clobazam | 1件: Clobazam
Clobazam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 💬
|
784 | Clobazam medium dose | 1件: Clobazam Clobazam | 1件: Clobazam
Clobazam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 💬
|
785 | Clobazam tablets 10MG | 1件: Clobazam Clobazam | 1件: Clobazam
Clobazam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 💬
|
786 | Clobazam tablets 20MG | 1件: Clobazam Clobazam | 1件: Clobazam
Clobazam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 💬
|
787 | Clobazam tablets 5MG | 1件: Clobazam Clobazam | 1件: Clobazam
Clobazam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 144 144 💬
|
788 | Clobetasol | 1件: Clobetasol Clobetasol | 1件: Clobetasol
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 💬
|
789 | Clobetasol 0.05% ointment | 1件: Clobetasol Clobetasol | 1件: Clobetasol
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 39 39 💬
|
790 | Clobetasol 0.05% topical ointment | 1件: Clobetasol Clobetasol | 1件: Clobetasol
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
791 | Clobetasol decreasing measurement | 1件: Clobetasol Clobetasol | 1件: Clobetasol
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
792 | Clobetasol propionate | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 162 💬
|
793 | Clobetasol propionate + methotrexate | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
794 | Clobetasol propionate alone | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
795 | Clobetasol propionate cream treatment | 2件: Clobetasol Clobetasol, Clobetasol propionate | 2件: Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 162 162 💬
|
796 | Clobetasolo propionato | - | - | - | - | 1件: 162 162 💬
|
797 | Clofarabine | 1件: Clofarabine Clofarabine | 1件: Clofarabine
Clofarabine
💬
| 3件: POLA1 POLA1, POLA2, RRM1 💬
| 5件: DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 5件: 19 19, 20, 60, 96, 234 💬
|
798 | Clofazimine | 1件: Clofazimine Clofazimine | 1件: Clofazimine
Clofazimine
💬
| - | - | 1件: 96 96 💬
|
799 | Clomiphene citrate | 1件: Clomifene Clomifene | 2件: Clomiphene citrate
Clomiphene citrate
,
Clomifene
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 74 74, 77 💬
|
800 | Clonazepam | 1件: Clonazepam Clonazepam | 1件: Clonazepam
Clonazepam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 💬
|
801 | Clonidine | 1件: Clonidine Clonidine | 2件: Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
802 | Clonidine hydrochloride | 1件: Clonidine Clonidine | 2件: Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
803 | Clonidinhydrochlorid | - | - | - | - | 1件: 65 65 💬
|
804 | Clopidogrel | 1件: Clopidogrel Clopidogrel | 4件: Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| 1件: P2RY12 P2RY12 💬
| 3件: Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | 4件: 40 40, 49, 51, 86 💬
|
805 | Clopidogrel treatment | 1件: Clopidogrel Clopidogrel | 4件: Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| 1件: P2RY12 P2RY12 💬
| 3件: Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | 1件: 51 51 💬
|
806 | Cloramfenicolo fisiopharma - 1 G/10 ML polvere E solvente PER soluzione iniettabile PER USO endovenoso 1 flaconcino polvere + 1 fiala solvente DA 10 ML | - | - | - | - | 1件: 90 90 💬
|
807 | Clorfenamina maleato | 1件: Chlorpheniramine Chlorpheniramine | 2件: Chlorpheniramine maleate
Chlorpheniramine maleate
,
Chlorphenamine
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 14 14 💬
|
808 | Cloruro DI potassio | - | - | - | - | 1件: 97 97 💬
|
809 | Cloruro DI sodio | - | - | - | - | 1件: 97 97 💬
|
810 | Close follow-UP | - | - | - | - | 2件: 58 58, 59 💬
|
811 | Clostridium botulinum toxin type A | 2件: Botulinum toxin type A Botulinum toxin type A, Clostridium botulinum | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 💬
|
812 | Clotrimazole | 1件: Clotrimazole Clotrimazole | 1件: Clotrimazole
Clotrimazole
💬
| - | - | 1件: 97 97 💬
|
813 | Clozapine | 1件: Clozapine Clozapine | 1件: Clozapine
Clozapine
💬
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2, HTR2, HTR3, HTR3, HTR3, HTR3, HTR3 💬
| 10件: Calcium signaling pathway Calcium signaling pathway, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
814 | CLS12311 | - | - | - | - | 1件: 13 13 💬
|
815 | CLS12311 high | - | - | - | - | 1件: 13 13 💬
|
816 | CLS12311 LOW | - | - | - | - | 1件: 13 13 💬
|
817 | CLS12311 medium | - | - | - | - | 1件: 13 13 💬
|
818 | CLTX-305 | - | - | - | - | 1件: 235 235 💬
|
819 | Cluvot | - | - | - | - | 1件: 288 288 💬
|
820 | CLZ-2002 | 1件: CLZ-2002 CLZ-2002 | - | - | - | 1件: 10 10 💬
|
821 | CM-101 | 1件: CM-101 CM-101 | - | - | - | 2件: 51 51, 94 💬
|
822 | CM-336 bcma/CD3 bispecific antibody | - | - | - | - | 1件: 28 28 💬
|
823 | CM310 | - | - | - | - | 1件: 300 300 💬
|
824 | CM313 | - | - | - | - | 1件: 66 66 💬
|
825 | CM313 injection | - | - | - | - | 3件: 35 35, 49, 63 💬
|
826 | CM313(SC) injection | - | - | - | - | 1件: 60 60 💬
|
827 | CM336 injection | - | - | - | - | 1件: 63 63 💬
|
828 | CM338 | - | - | - | - | 1件: 66 66 💬
|
829 | CMAB008 | - | - | - | - | 1件: 46 46 💬
|
830 | CME-LEM4 | - | - | - | - | 1件: 117 117 💬
|
831 | CMK389 | - | - | - | - | 1件: 84 84 💬
|
832 | CMR316 | - | - | - | - | 1件: 85 85 💬
|
833 | Cmri | - | - | - | - | 3件: 51 51, 77, 86 💬
|
834 | CMS | - | - | - | - | 1件: 299 299 💬
|
835 | CMTS0929 | - | - | - | - | 1件: 97 97 💬
|
836 | CMTX-101 | - | - | - | - | 1件: 299 299 💬
|
837 | CNCT19 CAR-T cell therapy | - | - | - | - | 1件: 61 61 💬
|
838 | CNCT19 cell injection | - | - | - | - | 1件: 49 49 💬
|
839 | CNM-AU8 | 1件: CNM-Au8 CNM-Au8 | - | - | - | 2件: 2 2, 13 💬
|
840 | Cnmau8 | - | - | - | - | 1件: 2 2 💬
|
841 | CNP-104 | - | - | - | - | 1件: 93 93 💬
|
842 | CNP-106 | - | - | - | - | 1件: 11 11 💬
|
843 | CNP-MS-0601 | - | - | - | - | 1件: 13 13 💬
|
844 | CNS10-NPC implantation | - | - | - | - | 1件: 90 90 💬
|
845 | CNS10-NPC-gdnf | - | - | - | - | 1件: 2 2 💬
|
846 | CNSA-001 | - | - | - | - | 1件: 240 240 💬
|
847 | CNT-02 | - | - | - | - | 1件: 160 160 💬
|
848 | Cnto 1275 | - | - | - | - | 2件: 13 13, 96 💬
|
849 | Cnto 136 | - | - | - | - | 2件: 41 41, 46 💬
|
850 | Cnto 136 100 MG | - | - | - | - | 1件: 46 46 💬
|
851 | Cnto 136 25 MG | - | - | - | - | 1件: 46 46 💬
|
852 | Cnto 136 50 MG | - | - | - | - | 1件: 46 46 💬
|
853 | Cnto 136 IGG | - | - | - | - | 1件: 46 46 💬
|
854 | Cnto 148 | - | - | - | - | 4件: 46 46, 84, 97, 271 💬
|
855 | Cnto 1959 | - | - | - | - | 1件: 46 46 💬
|
856 | Cnto 1959 IGG | - | - | - | - | 1件: 46 46 💬
|
857 | Cnto 2476 | - | - | - | - | 1件: 90 90 💬
|
858 | Cnto 328 | - | - | - | - | 1件: 331 331 💬
|
859 | Cnto 6785 100 MG | - | - | - | - | 1件: 46 46 💬
|
860 | Cnto 6785 15 MG | - | - | - | - | 1件: 46 46 💬
|
861 | Cnto 6785 200 MG | - | - | - | - | 1件: 46 46 💬
|
862 | Cnto 6785 50 MG | - | - | - | - | 1件: 46 46 💬
|
863 | Cnto 888 1 MG/KG | - | - | - | - | 1件: 85 85 💬
|
864 | Cnto 888 15 MG/KG | - | - | - | - | 1件: 85 85 💬
|
865 | Cnto 888 5 MG/KG | - | - | - | - | 1件: 85 85 💬
|
866 | CNTO-148 | - | - | - | - | 1件: 97 97 💬
|
867 | CNTO1275 | - | - | - | - | 6件: 46 46, 49, 84, 93, 96, 97 💬
|
868 | CNTO136 | - | - | - | - | 1件: 46 46 💬
|
869 | CNTO148 | - | - | - | - | 5件: 46 46, 84, 96, 97, 107 💬
|
870 | CNTO1959 | - | - | - | - | 4件: 37 37, 41, 96, 97 💬
|
871 | CNTO312 | - | - | - | - | 1件: 97 97 💬
|
872 | CNTO328 | - | - | - | - | 1件: 331 331 💬
|
873 | CNTO6785 | - | - | - | - | 1件: 46 46 💬
|
874 | CNTO888 | - | - | - | - | 1件: 85 85 💬
|
875 | CNTY-101 | - | - | - | - | 2件: 49 49, 51 💬
|
876 | CO-14 | - | - | - | - | 1件: 13 13 💬
|
877 | CO-medication: synthetic dmards | - | - | - | - | 1件: 46 46 💬
|
878 | CO-transplantation OF FMT and pectin | - | - | - | - | 1件: 97 97 💬
|
879 | CO-trimoxazole | - | - | - | - | 1件: 85 85 💬
|
880 | CO2 laser | - | - | - | - | 1件: 51 51 💬
|
881 | Coaching sessions | - | - | - | - | 1件: 49 49 💬
|
882 | Coagadex | - | - | - | - | 2件: 28 28, 288 💬
|
883 | CoagulacióN factor viii | - | - | - | - | 1件: 288 288 💬
|
884 | Coagulation factor viii | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
885 | Coagulation factor xiii | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 💬
|
886 | Coamoxiclav | - | - | - | - | 1件: 97 97 💬
|
887 | Coarse wheat bran | - | - | - | - | 1件: 6 6 💬
|
888 | Cobalt | 1件: Cobalt Cobalt | - | - | - | 1件: 46 46 💬
|
889 | Cobalt™ bone cement | 1件: Cobalt Cobalt | - | - | - | 1件: 46 46 💬
|
890 | Cobamamide | 1件: Cobamamide Cobamamide | 1件: Cobamamide
Cobamamide
💬
| - | - | 1件: 299 299 💬
|
891 | Cobimetinib | 1件: Cobimetinib Cobimetinib | 2件: Cobimetinib
Cobimetinib
,
Cobimetinib fumarate
💬
| 2件: MAP2K1 MAP2K1, MAP2K2 💬
| 88件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 280 280 💬
|
892 | Cobiprostone | 1件: Cobiprostone Cobiprostone | 1件: Cobiprostone
Cobiprostone
💬
| - | - | 1件: 46 46 💬
|
893 | Cobitolimod | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
894 | Cobitolimod 250 MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
895 | Cobitolimod 500 MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
896 | Cobitolimod 500MG | 1件: Cobitolimod Cobitolimod | 1件: Cobitolimod
Cobitolimod
💬
| 1件: TLR9 TLR9 💬
| 9件: African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | 1件: 97 97 💬
|
897 | Cocoa | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 💬
|
898 | Coconut OIL | 2件: Coconut Coconut, Coconut oil | 1件: Coconut oil
Coconut oil
💬
| - | - | 1件: 13 13 💬
|
899 | Coconut OIL and epigallocatechin gallate | 2件: Coconut Coconut, Coconut oil | 1件: Coconut oil
Coconut oil
💬
| - | - | 1件: 13 13 💬
|
900 | COD liver OIL | 1件: Cod liver oil Cod liver oil | 1件: Cod liver oil
Cod liver oil
💬
| - | - | 1件: 46 46 💬
|
901 | Code ATC:L01xc04 | - | - | - | - | 1件: 65 65 💬
|
902 | Coduse balance training and step square exercises | - | - | - | - | 1件: 13 13 💬
|
903 | Coenzym Q10 nanodispersion | - | - | - | - | 1件: 5 5 💬
|
904 | Coenzym Q10, ubiquinon, ubichinon | - | - | - | - | 1件: 5 5 💬
|
905 | Coenzyme Q | - | - | - | - | 1件: 13 13 💬
|
906 | Coenzyme Q-10 IN normal control subjects | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 86 86 💬
|
907 | Coenzyme Q-10 IN pulmonary hypertension subjects | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 86 86 💬
|
908 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 12件: 2 2, 5, 6, 8, 10, 46, 57, 107, 113, 193, 214, 215 💬
|
909 | Coenzyme Q10 and lisinopril | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 113 113 💬
|
910 | Coenzyme Q10 with vitamin E | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 6 6 💬
|
911 | Coenzymeq10 | - | - | - | - | 1件: 21 21 💬
|
912 | Coffee | - | - | - | - | 1件: 96 96 💬
|
913 | Coffee coal | - | - | - | - | 1件: 97 97 💬
|
914 | Coffee consumption | - | - | - | - | 1件: 46 46 💬
|
915 | Cognitive and behavioral experimental tasks | - | - | - | - | 1件: 127 127 💬
|
916 | Cognitive battery | - | - | - | - | 1件: 6 6 💬
|
917 | Cognitive evaluation | - | - | - | - | 1件: 8 8 💬
|
918 | Cognitive training | - | - | - | - | 1件: 206 206 💬
|
919 | Cohort 1 0.225G | - | - | - | - | 1件: 240 240 💬
|
920 | Cohort 1: 1.0 X 10^8 polytregs | - | - | - | - | 1件: 35 35 💬
|
921 | Cohort 1: hatg, CSA, epag DAY 14 TO month 6 | - | - | - | - | 1件: 60 60 💬
|
922 | Cohort 1: JMKX003142 and itraconazole | - | - | - | - | 1件: 67 67 💬
|
923 | Cohort 2 0.75G | - | - | - | - | 1件: 240 240 💬
|
924 | Cohort 2: 2.5x10^8 polytregs | - | - | - | - | 1件: 35 35 💬
|
925 | Cohort 2: hatg, CSA, epag DAY 14 TO month 3 | - | - | - | - | 1件: 60 60 💬
|
926 | Cohort 2: JMKX003142 and rifampicin | - | - | - | - | 1件: 67 67 💬
|
927 | Cohort 3 2.25 G | - | - | - | - | 1件: 240 240 💬
|
928 | Cohort 3: hatg, CSA (dose reduced), epag DAY 1 TO month 6 | - | - | - | - | 1件: 60 60 💬
|
929 | Cohort1 | - | - | - | - | 1件: 6 6 💬
|
930 | Cohort2 | - | - | - | - | 1件: 6 6 💬
|
931 | COL7a1-SIN retroviral vector engineered autologous tissue-engineered skin | - | - | - | - | 1件: 36 36 💬
|
932 | Colal pred | - | - | - | - | 1件: 97 97 💬
|
933 | Colal-pred | - | - | - | - | 1件: 97 97 💬
|
934 | Colchicina lirca - 1 MG compresse 60 compresse | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬
|
935 | Colchicine | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 8件: 42 42, 46, 50, 56, 93, 97, 210, 266 💬
|
936 | Colchicine 1 MG oral tablet | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 💬
|
937 | Colchicine cessation | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬
|
938 | Colchicine level measurement | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬
|
939 | Colchicine sprinkle capsules | 1件: Colchicine Colchicine | 1件: Colchicine
Colchicine
💬
| 9件: TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| 11件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 💬
|
940 | Cold cadioplegia | - | - | - | - | 1件: 215 215 💬
|
941 | Colecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 13 13, 46, 96, 97, 228 💬
|
942 | Colectomy | - | - | - | - | 1件: 97 97 💬
|
943 | Colesevelam | 1件: Colesevelam Colesevelam | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | 1件: 96 96 💬
|
944 | Colesevelam hydrochloride | 1件: Colesevelam Colesevelam | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | 1件: 79 79 💬
|
945 | Colesevelam hydrochloride FILM-coated tablets | 1件: Colesevelam Colesevelam | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | 1件: 79 79 💬
|
946 | Colestipol | 1件: Colestipol Colestipol | 2件: Colestipol hydrochloride
Colestipol hydrochloride
,
Colestipol
💬
| - | - | 1件: 254 254 💬
|
947 | Colestiramina | 1件: Cholestyramine Cholestyramine | 1件: Cholestyramine resin
Cholestyramine resin
💬
| - | - | 1件: 13 13 💬
|
948 | Colestyramine | 1件: Cholestyramine Cholestyramine | 1件: Cholestyramine resin
Cholestyramine resin
💬
| - | - | 1件: 254 254 💬
|
949 | Colfinair 2 MIU powder FOR nebuliser solution | - | - | - | - | 1件: 299 299 💬
|
950 | Colimicina - 1000000 U/4 ML polvere E solvente PER soluzione iniettabile PER USO intramuscolare1 flaconcino polvere + 1 fiala solvente 4 ML | - | - | - | - | 1件: 299 299 💬
|
951 | Colimycine inhalation | - | - | - | - | 1件: 299 299 💬
|
952 | Colimycine injectable | - | - | - | - | 1件: 299 299 💬
|
953 | Colistimetato sodico | - | - | - | - | 1件: 299 299 💬
|
954 | Colistimethat-natrium | - | - | - | - | 1件: 299 299 💬
|
955 | Colistimethate | 1件: Colistimethate Colistimethate | 1件: Colistimethate sodium
Colistimethate sodium
💬
| - | - | 1件: 299 299 💬
|
956 | Colistimethate 75 MG inhaled TWO times daily | 1件: Colistimethate Colistimethate | 1件: Colistimethate sodium
Colistimethate sodium
💬
| - | - | 1件: 299 299 💬
|
957 | Colistimethate sodium | 1件: Colistimethate Colistimethate | 1件: Colistimethate sodium
Colistimethate sodium
💬
| - | - | 1件: 299 299 💬
|
958 | Colistimethate sodium (BAN, usan), colistimethatum natricum, colistin sodium methanesulfonate | 1件: Colistimethate Colistimethate | 1件: Colistimethate sodium
Colistimethate sodium
💬
| - | - | 1件: 299 299 💬
|
959 | Colistin | 1件: Colistin Colistin | 2件: Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | 1件: 299 299 💬
|
960 | Colistin CF | 1件: Colistin Colistin | 2件: Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | 1件: 299 299 💬
|
961 | Colistin forest - trockenstechampullen MIT Lösungsmittel | 1件: Colistin Colistin | 2件: Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | 1件: 299 299 💬
|
962 | Colistin mesilate sodium | 1件: Colistin Colistin | 2件: Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | 1件: 299 299 💬
|
963 | Colistineb 2MUI | - | - | - | - | 1件: 299 299 💬
|
964 | Collagenase | 1件: Collagenase clostridium histolyticum Collagenase clostridium histolyticum | 1件: Collagenase clostridium histolyticum
Collagenase clostridium histolyticum
💬
| - | - | 1件: 162 162 💬
|
965 | Collect OF 10 ML OF peripheric blood FOR DNA extraction | - | - | - | - | 1件: 46 46 💬
|
966 | Collection OF arterial pressure, metabolic data, kidney function, proteinuria and hematuria before and after katrio initiation | - | - | - | - | 1件: 299 299 💬
|
967 | Collection OF biological samples | - | - | - | - | 1件: 63 63 💬
|
968 | Collection OF blood and urine | - | - | - | - | 1件: 25 25 💬
|
969 | Collection OF CSF, blood, urine, saliva | - | - | - | - | 1件: 6 6 💬
|
970 | Collection OF samples | - | - | - | - | 4件: 49 49, 65, 95, 107 💬
|
971 | Collection OF samples OF blood and urine | - | - | - | - | 1件: 167 167 💬
|
972 | Colobreathe | 1件: Colistimethate Colistimethate | 1件: Colistimethate sodium
Colistimethate sodium
💬
| - | - | 1件: 299 299 💬
|
973 | Colomycin | - | - | - | - | 1件: 299 299 💬
|
974 | Colon KCC heptapeptide | - | - | - | - | 1件: 97 97 💬
|
975 | Colon preparation FOR colonoscopy | - | - | - | - | 1件: 97 97 💬
|
976 | Colonic lavage | - | - | - | - | 1件: 291 291 💬
|
977 | Colonoscopy | - | - | - | - | 2件: 96 96, 97 💬
|
978 | Colonoscopy with indigo-carmine chromoendoscopy | - | - | - | - | 1件: 97 97 💬
|
979 | Color fundus photography | - | - | - | - | 1件: 41 41 💬
|
980 | Colorectal biopsies | - | - | - | - | 1件: 97 97 💬
|
981 | Colored water | - | - | - | - | 1件: 97 97 💬
|
982 | Colovit capsule | - | - | - | - | 1件: 96 96 💬
|
983 | Coltect | - | - | - | - | 1件: 97 97 💬
|
984 | Combination antiviral therapy | - | - | - | - | 1件: 93 93 💬
|
985 | Combination fish OIL and borage seed OIL | 1件: Fish oil Fish oil | - | - | - | 1件: 46 46 💬
|
986 | Combination injection OF EPO and G-CSF | - | - | - | - | 1件: 6 6 💬
|
987 | Combination OF A single dose ANTI-CD20 antibody and bortezomib | - | - | - | - | 1件: 61 61 💬
|
988 | Combination OF dmards | - | - | - | - | 1件: 107 107 💬
|
989 | Combination OF fish OIL and colesevelam | - | - | - | - | 1件: 260 260 💬
|
990 | Combination OF minocycline and MTX or MTX alone | - | - | - | - | 1件: 46 46 💬
|
991 | Combination OF navepegritide and lonapegsomatropin administered AS TWO separate S.C. injections | - | - | - | - | 1件: 276 276 💬
|
992 | Combination OF protein A immunoadsorption, rituximab, dexamethasone plus azathioprine | - | - | - | - | 1件: 35 35 💬
|
993 | Combination OF rituximab with subcutaneous belimumab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 63 63 💬
|
994 | Combination OF thrombopoietin mimetic and cyclosporin A | - | - | - | - | 1件: 60 60 💬
|
995 | Combination oral budesonide and rectal hydrocortisone | - | - | - | - | 1件: 97 97 💬
|
996 | Combination steroid | - | - | - | - | 1件: 46 46 💬
|
997 | Combination therapy with vigabatrin and prednisolone | 1件: Vigabatrin Vigabatrin | 1件: Vigabatrin
Vigabatrin
💬
| 1件: ABAT ABAT 💬
| 6件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 1件: 145 145 💬
|
998 | Combination with dopamine agonist cabergoline | - | - | - | - | 1件: 77 77 💬
|
999 | Combination with somatostatin analogue octreotide | - | - | - | - | 1件: 77 77 💬
|
1000 | Combined balance and brisk walking training | - | - | - | - | 1件: 6 6 💬
|
1001 | Combined plasma exchange (PEX), rituximab, and corticosteroids | - | - | - | - | 1件: 85 85 💬
|
1002 | Combined therapy OF iguratimod and tofacitinib | - | - | - | - | 1件: 46 46 💬
|
1003 | Combivir | 2件: Lamivudine Lamivudine, Zidovudine | 2件: Lamivudine
Lamivudine
,
Zidovudine
💬
| - | - | 1件: 265 265 💬
|
1004 | Comirnaty | - | - | - | - | 2件: 46 46, 51 💬
|
1005 | Comirnaty concentrate FOR dispersion FOR injection | 1件: Tozinameran Tozinameran | 1件: Tozinameran
Tozinameran
💬
| - | - | 2件: 53 53, 299 💬
|
1006 | Comirnaty konzentrat ZUR herstellung einer injektionsdispersion | - | - | - | - | 1件: 13 13 💬
|
1007 | Commercial formulation etanercept | - | - | - | - | 1件: 46 46 💬
|
1008 | Common name: sialic acid | - | - | - | - | 1件: 30 30 💬
|
1009 | Communicative effectiveness survey | - | - | - | - | 1件: 2 2 💬
|
1010 | Companion diagnostic (CDX) testing | - | - | - | - | 1件: 97 97 💬
|
1011 | Comparative efficacy and safety OF thalidomide and sulfasalazine IN moderate TO severe ankylosing spondylitis: A REAL-world study from bangladesh | - | - | - | - | 1件: 271 271 💬
|
1012 | Comparator | - | - | - | - | 1件: 96 96 💬
|
1013 | Comparators | - | - | - | - | 1件: 54 54 💬
|
1014 | Complement C1 esterase inhibitor | 1件: Conestat alfa Conestat alfa | 1件: Conestat alfa
Conestat alfa
💬
| 3件: C1R C1R, C1S, KLKB1 💬
| 6件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 61 61, 65 💬
|
1015 | Complement protein C5 inhibitor | - | - | - | - | 1件: 13 13 💬
|
1016 | Complete physical examination | - | - | - | - | 1件: 113 113 💬
|
1017 | Complete, polymeric formula, fiber, lactose and gluten free | - | - | - | - | 1件: 107 107 💬
|
1018 | Complex task practice | - | - | - | - | 1件: 6 6 💬
|
1019 | Compound 1A | - | - | - | - | 2件: 246 246, 299 💬
|
1020 | Compound 21 | 1件: Buloxibutid Buloxibutid | 2件: Buloxibutid
Buloxibutid
,
Buloxibutid sodium
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
1021 | Compound thrombosis capsule SIG: 1.5G/TID | - | - | - | - | 1件: 90 90 💬
|
1022 | Compressa effervescente 0,5 MG DI budesonide PER USO orodispersibile | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
1023 | Compressa effervescente 1 MG DI budesonide PER USO orodispersibile | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
1024 | Compressed oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 1件: 97 97 💬
|
1025 | Computed tomography | - | - | - | - | 12件: 26 26, 28, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
1026 | Computed tomography lung subtraction iodine mapping | - | - | - | - | 1件: 88 88 💬
|
1027 | Computer game based balance and walking rehabilitation FOR individuals with parkinson'S disease | - | - | - | - | 1件: 6 6 💬
|
1028 | Computer-assisted telephone interview | - | - | - | - | 1件: 85 85 💬
|
1029 | Computerized tomography scan | - | - | - | - | 1件: 98 98 💬
|
1030 | Comtan | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
1031 | Comtan 200* 60 CPR 200 MG | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
1032 | Comtess | 1件: Entacapone Entacapone | 1件: Entacapone
Entacapone
💬
| 1件: COMT COMT 💬
| 3件: Dopaminergic synapse Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
1033 | Concerta | - | - | - | - | 1件: 203 203 💬
|
1034 | Concomitant medication | - | - | - | - | 1件: 49 49 💬
|
1035 | Concurrent exercise training | - | - | - | - | 1件: 113 113 💬
|
1036 | Conestat alfa | 1件: Conestat alfa Conestat alfa | 1件: Conestat alfa
Conestat alfa
💬
| 3件: C1R C1R, C1S, KLKB1 💬
| 6件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Phagosome, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 65 65 💬
|
1037 | Confirm RX | - | - | - | - | 1件: 86 86 💬
|
1038 | Confortid | - | - | - | - | 1件: 225 225 💬
|
1039 | Conjugated equine estrogens 0.625 MG/D + MPA 5 MG/D/10D | 1件: Conjugated estrogens Conjugated estrogens | 1件: Estrogens, conjugated
Estrogens, conjugated
💬
| - | - | 1件: 49 49 💬
|
1040 | Conscious sedation | - | - | - | - | 1件: 6 6 💬
|
1041 | Conservative measures FOR orthostatic hypotension | - | - | - | - | 2件: 6 6, 17 💬
|
1042 | Conservative rehabilitation | - | - | - | - | 1件: 149 149 💬
|
1043 | Conservative treatment | - | - | - | - | 1件: 291 291 💬
|
1044 | Continuation OF azathioprine | - | - | - | - | 1件: 49 49 💬
|
1045 | Continue their usual therapy | - | - | - | - | 1件: 66 66 💬
|
1046 | Continued ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
1047 | Continuous apomorphine infusion | - | - | - | - | 1件: 6 6 💬
|
1048 | Continuous glucose monitor | - | - | - | - | 2件: 65 65, 298 💬
|
1049 | Continuous glucose monitoring | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 2件: 75 75, 299 💬
|
1050 | Continuous infusion cefepime | - | - | - | - | 1件: 299 299 💬
|
1051 | Continuous infusion ceftazidime | - | - | - | - | 1件: 299 299 💬
|
1052 | Continuous infusion meropenem | - | - | - | - | 1件: 299 299 💬
|
1053 | Continuous infusion piperacillin tazobactam | - | - | - | - | 1件: 299 299 💬
|
1054 | Continuous infusion ticarcillin-clavulanate | - | - | - | - | 1件: 299 299 💬
|
1055 | Continuous intrajejunal infusion OF levodopa-carbidopa | - | - | - | - | 1件: 6 6 💬
|
1056 | Continuous oxygen | - | - | - | - | 1件: 90 90 💬
|
1057 | Continuous release dopamine agonists | - | - | - | - | 1件: 6 6 💬
|
1058 | Continuous subcutaneous lisuride infusion | - | - | - | - | 1件: 6 6 💬
|
1059 | Contrast enhanced ultrasound | - | - | - | - | 1件: 96 96 💬
|
1060 | Contrast enhanced voiding urosonography with urodynamic testing | - | - | - | - | 1件: 118 118 💬
|
1061 | Contrast media, magnetic resonance | - | - | - | - | 2件: 94 94, 96 💬
|
1062 | Contrast sensitivity measurement | - | - | - | - | 1件: 19 19 💬
|
1063 | Contrast-enhanced ultrasound | - | - | - | - | 1件: 41 41 💬
|
1064 | Control diet | - | - | - | - | 2件: 96 96, 97 💬
|
1065 | Control GEL | - | - | - | - | 1件: 36 36 💬
|
1066 | Control group 0.9% isotonic saline | - | - | - | - | 1件: 299 299 💬
|
1067 | Control group typically developing | - | - | - | - | 1件: 113 113 💬
|
1068 | Control group: mesalazine enema treatment | - | - | - | - | 1件: 97 97 💬
|
1069 | Control multivitamin | - | - | - | - | 1件: 299 299 💬
|
1070 | Control surgery | - | - | - | - | 1件: 6 6 💬
|
1071 | Control wound treatment | - | - | - | - | 1件: 36 36 💬
|
1072 | Controlled-release levodopa / carbidopa | - | - | - | - | 1件: 6 6 💬
|
1073 | Convection enhanced delivery/AAV2-gdnf | - | - | - | - | 1件: 6 6 💬
|
1074 | Conventional | - | - | - | - | 1件: 63 63 💬
|
1075 | Conventional balance exercise | - | - | - | - | 1件: 6 6 💬
|
1076 | Conventional balance training | - | - | - | - | 1件: 13 13 💬
|
1077 | Conventional dmard combination | - | - | - | - | 1件: 46 46 💬
|
1078 | Conventional dmards | - | - | - | - | 1件: 46 46 💬
|
1079 | Conventional drugs | - | - | - | - | 1件: 97 97 💬
|
1080 | Conventional IBD medical treatment | - | - | - | - | 1件: 97 97 💬
|
1081 | Conventional medication | - | - | - | - | 1件: 6 6 💬
|
1082 | Conventional pharmacotherapy | - | - | - | - | 1件: 49 49 💬
|
1083 | Conventional physiotherapy | - | - | - | - | 1件: 6 6 💬
|
1084 | Conventional surgery | - | - | - | - | 1件: 34 34 💬
|
1085 | Conventional synthetic antirheumatic drugs | - | - | - | - | 1件: 46 46 💬
|
1086 | Conventional synthetic dmard | - | - | - | - | 1件: 46 46 💬
|
1087 | Conventional therapy | - | - | - | - | 5件: 6 6, 49, 67, 97, 222 💬
|
1088 | Conventional therapy users FOR THE last 5 years | - | - | - | - | 1件: 271 271 💬
|
1089 | Conventional treatment | - | - | - | - | 2件: 96 96, 97 💬
|
1090 | Conventional white-light colonoscopy | - | - | - | - | 1件: 97 97 💬
|
1091 | Coolonic biopsies | - | - | - | - | 2件: 96 96, 97 💬
|
1092 | Coozar | - | - | - | - | 1件: 167 167 💬
|
1093 | COP-1/copolymer-1 | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1094 | Copanlisib | 1件: Copanlisib Copanlisib | 1件: Copanlisib
Copanlisib
💬
| 2件: PIK3CA_B_D PIK3CA_B_D, PIK3CA_B_D 💬
| 103件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 121 121 💬
|
1095 | Copaxone | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1096 | Copaxone - 20 MG/ML soluzione iniettabile 28 siringhe preriempite | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1097 | Copaxone - 20 MG/ML soluzione iniettabile IN siringhe preriempite 30 siringhe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1098 | Copaxone - 40 MG/ML soluzione iniettabile IN | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1099 | Copaxone - 40 MG/ML soluzione iniettabile IN siringa preriempita 12 siringhe preriempite DA 1 ML CON AGO | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1100 | Copaxone 20 MG | - | - | - | - | 1件: 13 13 💬
|
1101 | Copaxone 20 MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1102 | Copaxone 20 MG/ML solucióN inyectable EN jeringa precargada | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1103 | Copaxone 20 MG/ML solucióN para inyeccióN EN jeringa precargada | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1104 | Copaxone 20 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1105 | Copaxone 20 MG/ML, solution FOR injection, PRE-filled syringes | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1106 | Copaxone 20MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1107 | Copaxone 40 MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1108 | Copaxone 40 MG/ML solution FOR injection, PRE-filled syringe | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1109 | Copaxone*SC 28SIR 20MG/ML | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 1件: 13 13 💬
|
1110 | Copaxone-teva | - | - | - | - | 1件: 13 13 💬
|
1111 | Copegus | 1件: Ribavirin Ribavirin | 1件: Ribavirin
Ribavirin
💬
| - | - | 1件: 2 2 💬
|
1112 | Copolymer 1 | - | - | - | - | 1件: 13 13 💬
|
1113 | Copper | 1件: Copper Copper | - | - | - | 2件: 169 169, 171 💬
|
1114 | Copper (64CU) chloride | 1件: Copper Copper | - | - | - | 1件: 171 171 💬
|
1115 | Copper histidinate | 1件: Copper Copper | - | - | - | 1件: 169 169 💬
|
1116 | Copper histidine | 2件: Copper Copper, Histidine | 1件: Histidine
Histidine
💬
| - | - | 2件: 169 169, 170 💬
|
1117 | COQ10 | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 4件: 5 5, 6, 8, 96 💬
|
1118 | Coqun | - | - | - | - | 1件: 90 90 💬
|
1119 | COR-003 | - | - | - | - | 1件: 75 75 💬
|
1120 | Cord blood | - | - | - | - | 1件: 60 60 💬
|
1121 | Cord blood infusion | - | - | - | - | 1件: 60 60 💬
|
1122 | Cord blood sampling | - | - | - | - | 1件: 227 227 💬
|
1123 | Cord blood transplant | - | - | - | - | 1件: 60 60 💬
|
1124 | Cord blood units | - | - | - | - | 1件: 60 60 💬
|
1125 | Cord sampling | - | - | - | - | 1件: 227 227 💬
|
1126 | Core stability | - | - | - | - | 1件: 13 13 💬
|
1127 | Core stabilization exercises | - | - | - | - | 1件: 6 6 💬
|
1128 | Cormeto - 250 MG capsule molli 50 capsule IN flacone hdpe | - | - | - | - | 1件: 75 75 💬
|
1129 | Corn OIL capsules | 1件: Corn Corn | - | - | - | 1件: 46 46 💬
|
1130 | Corn starch | 1件: Starch, corn Starch, corn | 1件: Corn starch
Corn starch
💬
| - | - | 2件: 49 49, 97 💬
|
1131 | Corn/SOY OIL | 1件: Corn Corn | - | - | - | 1件: 240 240 💬
|
1132 | Cornstarch | 1件: Starch, corn Starch, corn | 1件: Corn starch
Corn starch
💬
| - | - | 1件: 257 257 💬
|
1133 | Cornstarch control | 1件: Starch, corn Starch, corn | 1件: Corn starch
Corn starch
💬
| - | - | 1件: 90 90 💬
|
1134 | CORT113176 | - | - | - | - | 1件: 2 2 💬
|
1135 | CORT125134 | 1件: Relacorilant Relacorilant | 1件: Relacorilant
Relacorilant
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 💬
|
1136 | Cortancyl | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
1137 | Cortancyl 20 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 💬
|
1138 | Cortancyl ® 1 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
1139 | Cortancyl ® 20 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
1140 | Cortancyl ® 5 MG | 1件: Prednisone acetate Prednisone acetate | 1件: Prednisone acetate
Prednisone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬
|
1141 | Cortecosteroid | - | - | - | - | 1件: 96 96 💬
|
1142 | Cortef | - | - | - | - | 2件: 81 81, 83 💬
|
1143 | Cortef 10MG | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
1144 | Cortef 5 MG | - | - | - | - | 1件: 83 83 💬
|
1145 | Cortef 5MG | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
1146 | Corticoids+ tocilizumab 8MG/KG/4 weeks | - | - | - | - | 1件: 41 41 💬
|
1147 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
1148 | Corticosteroid and azathioprine | - | - | - | - | 4件: 42 42, 43, 44, 45 💬
|
1149 | Corticosteroid injection | - | - | - | - | 1件: 46 46 💬
|
1150 | Corticosteroid or nsaid | - | - | - | - | 1件: 46 46 💬
|
1151 | Corticosteroide | - | - | - | - | 1件: 113 113 💬
|
1152 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
|
1153 | Corticosteroids & tancart19/20 | - | - | - | - | 1件: 13 13 💬
|
1154 | Corticosteroids and immunosuppressants | - | - | - | - | 1件: 55 55 💬
|
1155 | Corticosteroids combined with immunoglobulin and romiplostim | - | - | - | - | 1件: 63 63 💬
|
1156 | Corticosteroids FOR systemic USE | - | - | - | - | 1件: 41 41 💬
|
1157 | Corticosteroids only | - | - | - | - | 1件: 97 97 💬
|
1158 | Corticosteroids'therapy | - | - | - | - | 1件: 35 35 💬
|
1159 | Corticotherapy | - | - | - | - | 1件: 66 66 💬
|
1160 | Corticotrophin 80 units | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 46 46 💬
|
1161 | Corticotropin | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 78 78, 81 💬
|
1162 | Corticotropin-releasing hormone | 2件: Corticorelin Corticorelin, Corticotropin | 3件: Corticotropin
Corticotropin
,
Corticorelin
,
Corticotropin, repository
💬
| 3件: CRHR1 CRHR1, CRHR2, MC2R 💬
| 7件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 75 75, 205 💬
|
1163 | Cortimentmmx 9 MG | - | - | - | - | 1件: 97 97 💬
|
1164 | Cortisol | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
1165 | Cortisol level | 1件: Hydrocortisone Hydrocortisone | 1件: Hydrocortisone
Hydrocortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 💬
|
1166 | Cortison | - | - | - | - | 1件: 81 81 💬
|
1167 | Cortisone acetate | 3件: Cortisone Cortisone, Cortisone acetate, Hydrocortisone | 3件: Hydrocortisone
Hydrocortisone
,
Cortisone acetate
,
Cortisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬
|
1168 | Cosentyx | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 4件: 41 41, 107, 269, 271 💬
|
1169 | Cosentyx - 150 MG - soluzione iniettabile IN siringa preriempita -USO sottocutaneo - siringa (vetro) 1 ML (150MG/ML)- 2 siringhe preriempite | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 107 107 💬
|
1170 | Cosentyx 300 MG solution FOR injection IN PRE-filled syringe | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
1171 | Cosentyx 300MG solution FOR injection IN PRE-filled syringe | 1件: Secukinumab Secukinumab | 1件: Secukinumab
Secukinumab
💬
| 1件: IL17A IL17A 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | 1件: 41 41 💬
|
1172 | Cosintropina acetato | - | - | - | - | 1件: 113 113 💬
|
1173 | Cosmofer | - | - | - | - | 2件: 96 96, 97 💬
|
1174 | Cosmofer 50MG/ML solution FOR infusion or injection | - | - | - | - | 2件: 96 96, 97 💬
|
1175 | Costicosteroids | - | - | - | - | 1件: 26 26 💬
|
1176 | Cosyntropin | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
1177 | Cosyntropin acetate | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
1178 | Cosyntropin injectable suspension 1 MG/ML + vigabatrin | 2件: Tetracosactide Tetracosactide, Vigabatrin | 3件: Cosyntropin
Cosyntropin
,
Vigabatrin
,
Tetracosactide acetate
💬
| 2件: ABAT ABAT, MC2R 💬
| 12件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Hormone signaling, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | 1件: 145 145 💬
|
1179 | Cosyntropin injectable suspension, 1 MG/ML | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 145 145 💬
|
1180 | Cosyntropin stimulation test | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 83 83 💬
|
1181 | Cotoretigene toliparvovec | 1件: Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | 1件: 90 90 💬
|
1182 | Cotrimoxazole | - | - | - | - | 2件: 85 85, 97 💬
|
1183 | Cotton gauze with petrolatum | 1件: Cotton Cotton | - | - | - | 2件: 35 35, 162 💬
|
1184 | Cough monitor | - | - | - | - | 1件: 85 85 💬
|
1185 | Coversin | 1件: Nomacopan Nomacopan | 1件: Nomacopan
Nomacopan
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 💬
|
1186 | Coversyl | 1件: Perindopril Perindopril | 3件: Perindopril erbumine
Perindopril erbumine
,
Perindopril
,
Perindopril arginine
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 167 167 💬
|
1187 | Coversyl plus | - | - | - | - | 1件: 19 19 💬
|
1188 | Covid-19 vaccination | - | - | - | - | 1件: 13 13 💬
|
1189 | Covid-19 vaccine | - | - | - | - | 5件: 13 13, 46, 49, 51, 97 💬
|
1190 | Covid-19 vaccine astrazeneca | 1件: AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | 2件: 46 46, 51 💬
|
1191 | Covid-19 vaccine janssen suspension FOR injection | - | - | - | - | 1件: 299 299 💬
|
1192 | Covid-19 vaccine moderna | - | - | - | - | 4件: 46 46, 51, 65, 272 💬
|
1193 | Covid-19 vaccine moderna dispersion FOR injection | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: Elasomeran
Elasomeran
💬
| - | - | 1件: 299 299 💬
|
1194 | Covid-19 vaccines AT A 3-month interval | - | - | - | - | 2件: 46 46, 97 💬
|
1195 | Covid-19 vaccines AT A 6-month interval | - | - | - | - | 2件: 46 46, 97 💬
|
1196 | Covid19 vaccine | - | - | - | - | 1件: 13 13 💬
|
1197 | Cozaar | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
1198 | Cozaar 50 | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
1199 | Cozaar 50 MG comprimidos recubierto CON pelicula | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 179 179 💬
|
1200 | Cozaar inicio 12,5 MG comprimidos recubiertos CON pelicula | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
1201 | CP 690,550 | - | - | - | - | 1件: 46 46 💬
|
1202 | CP 690550 MR | - | - | - | - | 1件: 46 46 💬
|
1203 | CP- 690 550 | - | - | - | - | 1件: 97 97 💬
|
1204 | CP-101 | - | - | - | - | 1件: 97 97 💬
|
1205 | CP-195,543 | - | - | - | - | 1件: 46 46 💬
|
1206 | CP-461 | - | - | - | - | 1件: 96 96 💬
|
1207 | CP-690, 550 - 10 | - | - | - | - | 1件: 46 46 💬
|
1208 | CP-690,500 5 MG | - | - | - | - | 1件: 97 97 💬
|
1209 | CP-690,55-10 | - | - | - | - | 1件: 46 46 💬
|
1210 | CP-690,550 | - | - | - | - | 4件: 46 46, 96, 97, 107 💬
|
1211 | CP-690,550 + methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 46 46 💬
|
1212 | CP-690,550 10 MG | - | - | - | - | 1件: 97 97 💬
|
1213 | CP-690,550 – 10 | - | - | - | - | 1件: 46 46 💬
|
1214 | CP-690,550-10 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
1215 | CP-690-550 | - | - | - | - | 1件: 46 46 💬
|
1216 | CP-690-550-10 | - | - | - | - | 1件: 107 107 💬
|
1217 | CP690,550 | - | - | - | - | 2件: 46 46, 97 💬
|
1218 | Cpap group: postoperative cpap support, NON-cpap group: oxygen 3 liters PER minute (L/MIN) either VIA mask FOR those WHO were extubated or through A T-piece FOR those with A trash | - | - | - | - | 1件: 330 330 💬
|
1219 | CPK850 | - | - | - | - | 1件: 90 90 💬
|
1220 | CPL409116 | - | - | - | - | 1件: 46 46 💬
|
1221 | CPL500036 | - | - | - | - | 1件: 6 6 💬
|
1222 | CPL500036 - high dose | - | - | - | - | 1件: 6 6 💬
|
1223 | CPL500036 - LOW dose | - | - | - | - | 1件: 6 6 💬
|
1224 | CPP | - | - | - | - | 1件: 76 76 💬
|
1225 | CPSI-2364 | - | - | - | - | 1件: 96 96 💬
|
1226 | CPX | - | - | - | - | 1件: 299 299 💬
|
1227 | CR 1 | - | - | - | - | 1件: 46 46 💬
|
1228 | CR 2 | - | - | - | - | 1件: 46 46 💬
|
1229 | CR 3 | - | - | - | - | 1件: 46 46 💬
|
1230 | CR002 liquid API | 1件: CR002 CR002 | - | - | - | 1件: 299 299 💬
|
1231 | CR0686 | - | - | - | - | 1件: 46 46 💬
|
1232 | CR13C | - | - | - | - | 1件: 113 113 💬
|
1233 | CR6086 | 1件: CR6086 CR6086 | - | - | - | 1件: 46 46 💬
|
1234 | CR6086Z | - | - | - | - | 1件: 46 46 💬
|
1235 | CR845 1.0 MG | - | - | - | - | 1件: 93 93 💬
|
1236 | Cranberry | 1件: Cranberry Cranberry | - | - | - | 1件: 13 13 💬
|
1237 | CRC3357, ZK-355322, leukoton | - | - | - | - | 1件: 299 299 💬
|
1238 | CRD-TMH-001 | - | - | - | - | 1件: 113 113 💬
|
1239 | CRD007 | - | - | - | - | 1件: 113 113 💬
|
1240 | Creapure | - | - | - | - | 1件: 50 50 💬
|
1241 | Creatine | 1件: Creatine Creatine | - | - | - | 10件: 1 1, 2, 6, 8, 13, 46, 49, 50, 201, 337 💬
|
1242 | Creatine chemical exchange saturation transfer (crcest) imaging sequence | 1件: Creatine Creatine | - | - | - | 1件: 21 21 💬
|
1243 | Creatine monohydrate | 1件: Creatine Creatine | - | - | - | 5件: 2 2, 8, 97, 113, 156 💬
|
1244 | Creatine-13C | 1件: Creatine Creatine | - | - | - | 1件: 113 113 💬
|
1245 | Creatinine | 1件: Creatinine Creatinine | 1件: Creatinine
Creatinine
💬
| - | - | 6件: 2 2, 46, 60, 66, 70, 222 💬
|
1246 | Crefmirlimab | 1件: Crefmirlimab Crefmirlimab | - | - | - | 1件: 51 51 💬
|
1247 | Creon | - | - | - | - | 2件: 298 298, 299 💬
|
1248 | Creon 10.000, HåRDE enterokapsler | - | - | - | - | 1件: 299 299 💬
|
1249 | Creon 10000 | - | - | - | - | 2件: 298 298, 299 💬
|
1250 | Creon 10000 capsules | - | - | - | - | 1件: 299 299 💬
|
1251 | Creon 25.000, HåRDE enterokapsler | - | - | - | - | 1件: 299 299 💬
|
1252 | Creon 25000 | - | - | - | - | 2件: 298 298, 299 💬
|
1253 | Creon 40.000, HåRDE enterokapsler | - | - | - | - | 1件: 299 299 💬
|
1254 | Creon IR | - | - | - | - | 1件: 299 299 💬
|
1255 | Creon N | - | - | - | - | 1件: 299 299 💬
|
1256 | Creon N 25000 | - | - | - | - | 1件: 299 299 💬
|
1257 | Creon® 25,000 | - | - | - | - | 1件: 299 299 💬
|
1258 | Crestor | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 3件: 49 49, 79, 299 💬
|
1259 | Crestor FILM-coated tablet | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 💬
|
1260 | Crestor tablets (calcium rosuvastatin) FILM-coated tablets | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 79 79 💬
|
1261 | Crexont ER | - | - | - | - | 1件: 6 6 💬
|
1262 | CRG003 injection | - | - | - | - | 1件: 256 256 💬
|
1263 | CRH | - | - | - | - | 1件: 310 310 💬
|
1264 | CRH administration | - | - | - | - | 2件: 72 72, 78 💬
|
1265 | Crinecerfont | 1件: Crinecerfont Crinecerfont | 1件: Crinecerfont
Crinecerfont
💬
| 1件: CRHR1 CRHR1 💬
| 5件: Cushing syndrome Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 81 81 💬
|
1266 | Crizotinib | 1件: Crizotinib Crizotinib | 1件: Crizotinib
Crizotinib
💬
| 1件: ALK ALK 💬
| 3件: Non-small cell lung cancer Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬 | 2件: 2 2, 34 💬
|
1267 | CRN00808 | - | - | - | - | 1件: 77 77 💬
|
1268 | CRN00808 IS AN oral NON-peptide small molecule somatostatin receptor 2 (SST2) agonist | 1件: Somatostatin Somatostatin | 1件: Somatostatin
Somatostatin
💬
| 5件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| 5件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 77 77 💬
|
1269 | CRN00808 è UN agonista DEL recettore 2 della somatostatina (SST2), orale, NON peptidico A piccole dimensioni molecolari | - | - | - | - | 1件: 77 77 💬
|
1270 | CRN00808.HCL | - | - | - | - | 1件: 77 77 💬
|
1271 | CRN04894 | - | - | - | - | 1件: 81 81 💬
|
1272 | Crocin and apigenin | 1件: Crocin Crocin | - | - | - | 1件: 6 6 💬
|
1273 | Crohn'S disease | - | - | - | - | 3件: 56 56, 96, 97 💬
|
1274 | Crohn'S disease exclusion diet | - | - | - | - | 1件: 96 96 💬
|
1275 | Crohns disease exclusion diet + PEN | - | - | - | - | 1件: 96 96 💬
|
1276 | Cromoglicato disodico | - | - | - | - | 1件: 85 85 💬
|
1277 | Cromoglycate | 1件: Cromoglicic acid Cromoglicic acid | 1件: Cromoglicic acid
Cromoglicic acid
💬
| - | - | 1件: 85 85 💬
|
1278 | Cromolyn | 1件: Cromoglicic acid Cromoglicic acid | 1件: Cromoglicic acid
Cromoglicic acid
💬
| - | - | 2件: 2 2, 85 💬
|
1279 | Cromolyn sodium | 1件: Cromoglicic acid Cromoglicic acid | 1件: Cromoglicic acid
Cromoglicic acid
💬
| - | - | 1件: 85 85 💬
|
1280 | Crono five ambulatory pump | - | - | - | - | 1件: 86 86 💬
|
1281 | Crovalimab | 1件: Crovalimab Crovalimab | 1件: Crovalimab
Crovalimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 62 62, 109 💬
|
1282 | Crown | - | - | - | - | 1件: 96 96 💬
|
1283 | CRQ | - | - | - | - | 1件: 46 46 💬
|
1284 | CRX-102 | - | - | - | - | 1件: 46 46 💬
|
1285 | CRX-139 | 1件: CRx-139 CRx-139 | - | - | - | 1件: 46 46 💬
|
1286 | CRX-150 | - | - | - | - | 1件: 46 46 💬
|
1287 | Cryopreserved autologous CD34+ cells transduced with A lentiviral vector containing human sgsh gene | - | - | - | - | 1件: 19 19 💬
|
1288 | Cryopreserved autologous CD34+ cells transduced with pcclchim-P47 | - | - | - | - | 1件: 65 65 💬
|
1289 | Cryopreserved EFS-ADA LV transduced patient CD34+ cells | - | - | - | - | 1件: 65 65 💬
|
1290 | Cryopreserved G2scid lentiviral vector transduced patient CD34+ cells | - | - | - | - | 1件: 65 65 💬
|
1291 | Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells | - | - | - | - | 1件: 13 13 💬
|
1292 | Cryostor CS10 | - | - | - | - | 1件: 53 53 💬
|
1293 | Cryosupernatant plasma | - | - | - | - | 1件: 64 64 💬
|
1294 | Crystalline calcium carbonate | - | - | - | - | 1件: 235 235 💬
|
1295 | Crystalline calcium supplements | - | - | - | - | 1件: 235 235 💬
|
1296 | Crystalline cholesterol OIL-based suspension | - | - | - | - | 1件: 310 310 💬
|
1297 | Crysvita (burosumab-twza) treatment | 1件: Burosumab Burosumab | 1件: Burosumab
Burosumab
💬
| 1件: FGF23 FGF23 💬
| 11件: Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | 1件: 238 238 💬
|
1298 | CS (corticosteroids) only | - | - | - | - | 1件: 97 97 💬
|
1299 | CS-0777 tablets | - | - | - | - | 1件: 13 13 💬
|
1300 | CS0159 | - | - | - | - | 2件: 93 93, 94 💬
|
1301 | CS1 | - | - | - | - | 1件: 86 86 💬
|
1302 | CS1 administration | - | - | - | - | 1件: 86 86 💬
|
1303 | CS10br05 | - | - | - | - | 1件: 17 17 💬
|
1304 | CSA | - | - | - | - | 5件: 19 19, 49, 60, 63, 222 💬
|
1305 | CSA+ATG+herombopag | - | - | - | - | 1件: 60 60 💬
|
1306 | CSA+herombopag | - | - | - | - | 1件: 60 60 💬
|
1307 | Csdmards | - | - | - | - | 1件: 46 46 💬
|
1308 | CSF sampling | - | - | - | - | 1件: 13 13 💬
|
1309 | CSL312 | - | - | - | - | 2件: 65 65, 85 💬
|
1310 | CSL312 garadacimab | 1件: Garadacimab Garadacimab | 1件: Garadacimab
Garadacimab
💬
| 1件: F12 F12 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 65 65, 85 💬
|
1311 | CSL787 | - | - | - | - | 1件: 299 299 💬
|
1312 | CSL830 | - | - | - | - | 1件: 65 65 💬
|
1313 | CSS | - | - | - | - | 1件: 107 107 💬
|
1314 | CST-103 | - | - | - | - | 1件: 6 6 💬
|
1315 | CST-107 | - | - | - | - | 1件: 6 6 💬
|
1316 | CST-139 | - | - | - | - | 1件: 6 6 💬
|
1317 | CSTI-500 | - | - | - | - | 1件: 193 193 💬
|
1318 | CT scan | - | - | - | - | 2件: 65 65, 75 💬
|
1319 | CT- P10 | - | - | - | - | 1件: 46 46 💬
|
1320 | CT-G20 | - | - | - | - | 1件: 58 58 💬
|
1321 | CT-P10 | - | - | - | - | 1件: 46 46 💬
|
1322 | CT-P13 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
1323 | CT-P13 SC AUTO-injector | - | - | - | - | 1件: 46 46 💬
|
1324 | CT-P17 | - | - | - | - | 1件: 46 46 💬
|
1325 | CT-P17 SC | - | - | - | - | 1件: 46 46 💬
|
1326 | CT-P47 | - | - | - | - | 1件: 46 46 💬
|
1327 | CT-P53 | - | - | - | - | 1件: 13 13 💬
|
1328 | CT1 | - | - | - | - | 1件: 6 6 💬
|
1329 | CT103A cells | 1件: CT103A CT103A | - | - | - | 3件: 11 11, 13, 16 💬
|
1330 | CTH120 | - | - | - | - | 1件: 206 206 💬
|
1331 | CTI-1601 | 1件: CTI-1601 CTI-1601 | - | - | - | 1件: 18 18 💬
|
1332 | CTLA4IG | - | - | - | - | 4件: 46 46, 49, 96, 271 💬
|
1333 | CTX-4430 | - | - | - | - | 1件: 299 299 💬
|
1334 | CTX112 | - | - | - | - | 1件: 51 51 💬
|
1335 | CU(II)atsm | - | - | - | - | 2件: 2 2, 6 💬
|
1336 | CU-64 dotatate | - | - | - | - | 1件: 84 84 💬
|
1337 | CU104 | - | - | - | - | 1件: 97 97 💬
|
1338 | Cudetaxestat | 1件: Cudetaxestat Cudetaxestat | - | - | - | 1件: 85 85 💬
|
1339 | Cufence | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 2件: 58 58, 171 💬
|
1340 | CUG252 | - | - | - | - | 1件: 49 49 💬
|
1341 | Cultivated oral mucosal epithelial sheet transplantation | - | - | - | - | 2件: 38 38, 162 💬
|
1342 | Culture OF lymphoblastoid line from blood sample | - | - | - | - | 1件: 102 102 💬
|
1343 | Cultured allogeneic fibroblasts | - | - | - | - | 1件: 36 36 💬
|
1344 | Cultured thymus tissue | - | - | - | - | 1件: 65 65 💬
|
1345 | Cultured thymus tissue implantation and parental parathyroid transplantation | - | - | - | - | 1件: 65 65 💬
|
1346 | Cultured thymus tissue implantation with parathyroid transplantation | - | - | - | - | 1件: 65 65 💬
|
1347 | Cumulative corticosteroid exposure | - | - | - | - | 1件: 49 49 💬
|
1348 | Cupping | - | - | - | - | 1件: 70 70 💬
|
1349 | Cuprior | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
1350 | Cuprior 150 MG | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
1351 | Cuprior 150 MG FILM-coated tablets | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
1352 | Cuprior 150MG FILM-coated tablets | 1件: Triethylenetetramine Triethylenetetramine | 2件: Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | 1件: 171 171 💬
|
1353 | CURA-100 | - | - | - | - | 1件: 46 46 💬
|
1354 | Curcuma longa extract CPL formaat 00 23,2 X 8,5 MM 723 MG | 1件: Turmeric Turmeric | - | - | - | 1件: 299 299 💬
|
1355 | Curcuma longa rhizoma | 1件: Turmeric Turmeric | - | - | - | 1件: 96 96 💬
|
1356 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 10件: 13 13, 34, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
1357 | Curcumin supplementation | 1件: Curcumin Curcumin | - | - | - | 1件: 97 97 💬
|
1358 | Curie artificial intelligence (AI) cough monitor | - | - | - | - | 1件: 299 299 💬
|
1359 | Curosurf | - | - | - | - | 1件: 211 211 💬
|
1360 | Current treatment | - | - | - | - | 1件: 46 46 💬
|
1361 | Current treatment OF AL-CM | - | - | - | - | 1件: 28 28 💬
|
1362 | Currently available therapy IN THE community | - | - | - | - | 1件: 51 51 💬
|
1363 | Cushing'S syndrome confirmation | - | - | - | - | 1件: 75 75 💬
|
1364 | Custom device | - | - | - | - | 1件: 6 6 💬
|
1365 | Cutaneous biopsy | - | - | - | - | 1件: 162 162 💬
|
1366 | Cutaneous iontophoresis OF treprostinil | - | - | - | - | 1件: 51 51 💬
|
1367 | Cutaquig | - | - | - | - | 1件: 65 65 💬
|
1368 | CUV1647 | - | - | - | - | 1件: 254 254 💬
|
1369 | Cuvitru | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 1件: 65 65 💬
|
1370 | Cuvitru 200 MG/ML solution FOR subcutaneous injection | 1件: Human immunoglobulin G Human immunoglobulin G | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 1件: 65 65 💬
|
1371 | CV-MG01 | 1件: CV-MG01 CV-MG01 | - | - | - | 1件: 11 11 💬
|
1372 | CVD00118-E | - | - | - | - | 1件: 6 6 💬
|
1373 | CVL-751 | - | - | - | - | 1件: 6 6 💬
|
1374 | CVN424 | - | - | - | - | 1件: 6 6 💬
|
1375 | CVN424 150 MG | - | - | - | - | 1件: 6 6 💬
|
1376 | CVN424 75 MG | - | - | - | - | 1件: 6 6 💬
|
1377 | CVT-301 | - | - | - | - | 1件: 6 6 💬
|
1378 | CVT-301 35MG | - | - | - | - | 1件: 6 6 💬
|
1379 | CVT-301 50MG | - | - | - | - | 1件: 6 6 💬
|
1380 | CVT-301 high dose | - | - | - | - | 1件: 6 6 💬
|
1381 | CVT-301 LOW dose | - | - | - | - | 1件: 6 6 💬
|
1382 | CVT-301, LIP | - | - | - | - | 1件: 6 6 💬
|
1383 | CVXL-0107 | - | - | - | - | 1件: 6 6 💬
|
1384 | CX-016492 | - | - | - | - | 1件: 245 245 💬
|
1385 | CX-017950 | - | - | - | - | 1件: 245 245 💬
|
1386 | CX-4945 oral formulation | - | - | - | - | 1件: 331 331 💬
|
1387 | CX-8998 | - | - | - | - | 1件: 6 6 💬
|
1388 | CX401 | - | - | - | - | 1件: 96 96 💬
|
1389 | CX501 | 1件: CX501 CX501 | - | - | - | 1件: 36 36 💬
|
1390 | CX516 | 1件: CX516 CX516 | - | - | - | 1件: 206 206 💬
|
1391 | CX601 | - | - | - | - | 1件: 96 96 💬
|
1392 | CXA-10 | 1件: CXA-10 CXA-10 | - | - | - | 2件: 86 86, 222 💬
|
1393 | CY-ATG | - | - | - | - | 1件: 60 60 💬
|
1394 | CYA | - | - | - | - | 1件: 50 50 💬
|
1395 | CYB704 | - | - | - | - | 1件: 13 13 💬
|
1396 | Cyberknife | - | - | - | - | 1件: 6 6 💬
|
1397 | CYC | - | - | - | - | 1件: 40 40 💬
|
1398 | CYC202 | - | - | - | - | 1件: 299 299 💬
|
1399 | Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence IN situ hybridization (fish) assay | - | - | - | - | 1件: 28 28 💬
|
1400 | Cycling intervention | - | - | - | - | 1件: 6 6 💬
|
1401 | Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D) TRP-LY DI-aspartate | - | - | - | - | 1件: 75 75 💬
|
1402 | Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D) TRP-LY pamoate | - | - | - | - | 1件: 77 77 💬
|
1403 | Cyclo ((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LY DI-aspartate | - | - | - | - | 1件: 75 75 💬
|
1404 | Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LY pamoate | - | - | - | - | 1件: 77 77 💬
|
1405 | Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS pamoate | - | - | - | - | 1件: 77 77 💬
|
1406 | Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS-TYR(BZL)-PHE) DI-aspartate | - | - | - | - | 1件: 75 75 💬
|
1407 | Cyclo((diaminoethyl-carbamate)hypro-PHG-(D)TRP-LYS-TYR(BZL)-PHE) pamoate | - | - | - | - | 1件: 77 77 💬
|
1408 | Cyclophosfamide | - | - | - | - | 1件: 13 13 💬
|
1409 | Cyclophosphamid | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 66 66, 220 💬
|
1410 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
1411 | Cyclophosphamide + pred | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 283 283 💬
|
1412 | Cyclophosphamide 100 MG/KG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 19 19, 222 💬
|
1413 | Cyclophosphamide 100MG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1414 | Cyclophosphamide 1200 MG/KG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 19 19, 222 💬
|
1415 | Cyclophosphamide 150MG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1416 | Cyclophosphamide 50MG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1417 | Cyclophosphamide 50MG oral tablet | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 162 162 💬
|
1418 | Cyclophosphamide added TO standard immunosuppressive therapy with herombopag | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1419 | Cyclophosphamide and ATG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
1420 | Cyclophosphamide and fludarabine | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 3件: 11 11, 13, 16 💬
|
1421 | Cyclophosphamide and steroids | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 222 222 💬
|
1422 | Cyclophosphamide dose level 1 | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 65 65, 284 💬
|
1423 | Cyclophosphamide dose level 2 | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 65 65, 284 💬
|
1424 | Cyclophosphamide dose level 3 | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 65 65, 284 💬
|
1425 | Cyclophosphamide dose level 4 | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 65 65, 284 💬
|
1426 | Cyclophosphamide followed BY methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
1427 | Cyclophosphamide injection 1G | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 3件: 50 50, 51, 52 💬
|
1428 | Cyclophosphamide LD | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 49 49 💬
|
1429 | Cyclophosphamide monohydrate | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 4件: 13 13, 60, 96, 256 💬
|
1430 | Cyclophosphamide post transplant | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 65 65 💬
|
1431 | Cyclophosphamide, azathioprine,prednisone,methylprednisolone | 2件: Cyclophosphamide Cyclophosphamide, Prednisone | 3件: Cyclophosphamide
Cyclophosphamide
,
Prednisone
,
Cyclophosphamide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 42 42, 43, 45 💬
|
1432 | Cyclophosphamide, bortezomib, and dexamethasone (cybord) regimen | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 28 28 💬
|
1433 | Cyclophosphamide, fludarabine | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 285 285 💬
|
1434 | Cyclophosphamide, fludarabine, rabbit ATG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1435 | Cyclophosphamide, fludarabine, thymoglobulin | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1436 | Cyclophosphamide,campath IH and TBI | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1437 | Cyclophosphamide,cyclosporine A | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 60 60 💬
|
1438 | Cyclophosphamide-prednisone-azathioprine | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 49 49 💬
|
1439 | Cyclophosphamide/ATG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
1440 | Cyclophosphamide/azathioprine | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
1441 | Cyclophosphamide/glatiramer acetate | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
1442 | Cyclophosphamide/rituximab | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 13 13 💬
|
1443 | Cyclophosphamidum 500 MG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
1444 | Cycloserine | 1件: Cycloserine Cycloserine | 1件: Cycloserine
Cycloserine
💬
| - | - | 1件: 2 2 💬
|
1445 | Cyclosphamine | - | - | - | - | 1件: 85 85 💬
|
1446 | Cyclosporin | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 50 50, 54, 60, 63, 97, 107, 222, 274, 326 💬
|
1447 | Cyclosporin A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 46 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
|
1448 | Cyclosporin capsules | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
1449 | Cyclosporin, LOW dose steroid | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
1450 | Cyclosporine | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 28件: 11 11, 28, 40, 41, 42, 45, 46, 49, 50, 53, 56, 60, 61, 62, 63, 64, 65, 97, 107, 162, 164, 222, 226, 228, 283, 284, 285, 302 💬
|
1451 | Cyclosporine + BCX7353 | 2件: Berotralstat Berotralstat, Cyclosporine | 3件: Cyclosporine
Cyclosporine
,
Berotralstat
,
Berotralstat hydrochloride
💬
| 6件: KLKB1 KLKB1, PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 34件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Complement and coagulation cascades, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 65 65 💬
|
1452 | Cyclosporine 0.09% ophthalmic solution | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 53 53 💬
|
1453 | Cyclosporine A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 19 19, 20, 36, 49, 50, 58, 60, 107, 228, 234, 283 💬
|
1454 | Cyclosporine combine with mycophenolate mofetil | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 283 283 💬
|
1455 | Cyclosporine inhalation solution | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
1456 | Cyclosporine oral product | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 60 60, 97 💬
|
1457 | Cyclosporine pill | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 56 56 💬
|
1458 | Cyclosporine VS infliximab | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 97 97 💬
|
1459 | Cyclosporine-A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 95 95 💬
|
1460 | Cyclosporins | - | - | - | - | 4件: 53 53, 60, 65, 222 💬
|
1461 | Cycol | - | - | - | - | 1件: 97 97 💬
|
1462 | Cyklokapron | 1件: Tranexamic acid Tranexamic acid | 1件: Tranexamic acid
Tranexamic acid
💬
| 1件: PLG PLG 💬
| 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 65 65 💬
|
1463 | Cyklokapron tablets | 1件: Tranexamic acid Tranexamic acid | 1件: Tranexamic acid
Tranexamic acid
💬
| 1件: PLG PLG 💬
| 4件: Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | 1件: 65 65 💬
|
1464 | Cyklosporin A | - | - | - | - | 1件: 54 54 💬
|
1465 | Cyltezo | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
1466 | Cymbalta | 1件: Duloxetine Duloxetine | 2件: Duloxetine hydrochloride
Duloxetine hydrochloride
,
Duloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 49 💬
|
1467 | CYP substrates | - | - | - | - | 1件: 98 98 💬
|
1468 | CYR-064 | - | - | - | - | 1件: 6 6 💬
|
1469 | CYS | - | - | - | - | 1件: 96 96 💬
|
1470 | Cystadane anhydrous | - | - | - | - | 1件: 19 19 💬
|
1471 | Cystadrops | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1472 | Cystadrops 0.55% EYE drops, solution | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1473 | Cystagon | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 3件: 8 8, 19, 299 💬
|
1474 | Cystagon (cysteamine bitartrate) immediate-release capsules | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 299 299 💬
|
1475 | Cystagon 150MG | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1476 | Cystagon 50MG | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1477 | Cysteamine | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 2件: 19 19, 299 💬
|
1478 | Cysteamine (mercaptamine) viscous solution | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1479 | Cysteamine bitartrate | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 4件: 8 8, 19, 21, 299 💬
|
1480 | Cysteamine bitartrate (INN: mercaptamine bitartrate | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1481 | Cysteamine bitartrate delayed-release capsules | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1482 | Cysteamine hydrochloride | 1件: Cysteamine Cysteamine | 3件: Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | 1件: 19 19 💬
|
1483 | Cysteine | 1件: Cysteine Cysteine | 2件: L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | 2件: 90 90, 337 💬
|
1484 | Cysteine hydrochloride | 1件: Cysteine Cysteine | 2件: L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | 1件: 254 254 💬
|
1485 | Cystic fibrosis ready TO USE supplemental food | - | - | - | - | 1件: 299 299 💬
|
1486 | Cystic fibrosis transmembrane conductance regulator | 1件: Cystic fibrosis transmembrane conductance regulator Cystic fibrosis transmembrane conductance regulator | - | - | - | 1件: 299 299 💬
|
1487 | Cystoscopic injection OF botox into THE urinary bladder | - | - | - | - | 1件: 6 6 💬
|
1488 | CYT107 | - | - | - | - | 1件: 25 25 💬
|
1489 | Cytarabine | 1件: Cytarabine Cytarabine | 2件: Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | 7件: 11 11, 13, 14, 25, 34, 49, 60 💬
|
1490 | Cytochrome P450 (CYP) substrates | - | - | - | - | 2件: 96 96, 97 💬
|
1491 | Cytogenetic analysis | - | - | - | - | 1件: 285 285 💬
|
1492 | Cytokine essays | - | - | - | - | 1件: 61 61 💬
|
1493 | Cytokine-treated veto cells | - | - | - | - | 1件: 60 60 💬
|
1494 | Cytokines and chemokine profiling | - | - | - | - | 1件: 49 49 💬
|
1495 | Cytolytic CD4+ T cells | - | - | - | - | 1件: 13 13 💬
|
1496 | Cytoreductive regimen followed BY A CD34+E- selected allogeneic stem cell transplant | - | - | - | - | 1件: 62 62 💬
|
1497 | Cytotoxic combination | - | - | - | - | 1件: 56 56 💬
|
1498 | Cytoxan | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 60 60, 96 💬
|
1499 | CZP | - | - | - | - | 1件: 46 46 💬
|
1500 | Cápsulas DE laquinimod 0.6 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 13 13 💬
|
1501 | Células madre mesenquimales | - | - | - | - | 1件: 13 13 💬
|
1502 | Células madre mesenquimales DE tejido adiposo AUTólogo | - | - | - | - | 1件: 2 2 💬
|
1503 | Células madre mesenquimales haploidénticas derivadas DE Médula óSEA | - | - | - | - | 1件: 36 36 💬
|
1504 | Células mesenquimales DE tejido adiposo | - | - | - | - | 1件: 2 2 💬
|
1505 | Células mesenquimales troncales adultas alogénicas DE Médula óSEA NO expandidas | - | - | - | - | 1件: 274 274 💬
|
1506 | Células mesenquimales troncales adultas AUTólogas DE medula óSEA expandidas | - | - | - | - | 1件: 117 117 💬
|
1507 | Células mesenquimales troncales adultas AUTólogas DE Médula óSEA expandidas | - | - | - | - | 1件: 117 117 💬
|
1508 | Células troncales hematopoyéticas AUTólogas adultas extraidas DE Médula óSEA | - | - | - | - | 1件: 2 2 💬
|